This event will describe Development Goal 12: Pharmacy Intelligence and explore latest developments in data and intelligence that supports health care. It will identify practical approaches to progress towards Development Goal 12.

Aim:
To discuss development goal 12 and how to ensure it supports health care.

Learning objectives:
1. Define pharmacy intelligence and explain priorities for its development (FIP Development Goal 12)
2. Discuss approaches to community pharmacy data collection
3. Explain the METNA project and its approach to data collection and needs assessment
4. List the functions of the GPO Atlas
5. Analyse and comment on possible indicators for DG12

Moderator
Professor Robert Sindelar, Chair – One FIP Data and Intelligence Commission, Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada

Panelists and Speakers
- Christopher John, Lead for Data and Intelligence, FIP, UK

- António Rodrigues, Executive Director - Portuguese Association of Pharmacies, Portugal

- Farah Aqqad, Regional Engagement and Project Coordinator, FIP, Jordan

- Dr Mira Zugic, President of the Pharmaceutical Chamber of Montenegro

- Dr Tanniru Narayana/Dr Rao Vadlamudi – Indian Pharmaceutical Association

- Mr. Nurul Falah Eddy Pariang, President – Indonesian Pharmacists Association.

- Sherly Meilianti, Data and Intelligence Specialist, FIP, UK/Indonesia

This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

About the programme:
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

Moderator:
- Lina Bader - FIP Lead for Workforce Transformation & Development, Saudi Arabia 

Co-Moderator:
- Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay

Panellists:
- Daphne Holt, Chair of Coalition for Life-course Immunisation, France

- Meghna Joshi-Von Heyden, Strategic Development Advisor, Commonwealth Pharmacists Association (CPA), Switzerland

- Suresh Bhojraj, Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru, India

- Marleen Haems, Director of Professional Management, KOVAG / VAN, Belgium

- Katarina Milosevic Konstadinovic, Community Pharmacist, Chairman of Assembly of Pharmaceutical Chamber of Montenegro, Montenegro

Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines.
Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines.
2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications.
3- to identify emerging regional and global threats and challenges related to counterfeit medication.

Moderator:
- Lars-Åke Söderlund, President Swedish pharmaceutical society - Sweden 

Panellists:
- Catherine Duggan, CEO FIP, The Netherlands
- John Hertig, Vice-Chair and an Associate Professor of Pharmacy Practice, USA
- Manjiri Gharat, Vice-President, Indian Pharmaceutical Association, India
- Stephanie Kohl, Policy & Advocacy Officer, Belgium 
- Sally Galal, Associate Professor, Alexandria University, Egypt
- Dieudonne NZEYIMANA, Pharmacist and Sales Manager, Rwanda
- Renae Beardmore, Acting National President, Australia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
- Pierre Souverain, Pfizer
- Caitriona Scott, Pfizer
- Gudrun Hubinger, Pfizer
- Zuzana Kusynová, Lead for Policy, Practice and Compliance, FIP, The Netherlands

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1. Describe the characteristics and epidemiology of the main VBDs in the European region;
2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and
3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.

Moderator:
- Sari Westermarck, Community pharmacist, Finland

Panellists:
- Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes, Denmark

- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia, Spain

- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology, Turkey

- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union, Bulgaria

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 13 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 13 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 13
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
Catherine Duggan, CEO FIP, Netherlands

Panellists:
-Mahmoud Abdelrahman, President Egyptian Foundation of Clinical pharmacy EFCP, Egypt

- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP Australia

- Ramesh Walpola, Senior Lecturer School of Population Health, UNSW Sydney, Australia

-Virginia Olmos, Vice President AQFU, Uruguay

- Subhash Mandal, Vice President, Indian Pharmaceutical Association, India

- Ema Paulino, FIP Professional Secretar; Policy committee for statement on Women and RUM (Chair); General Manager, Ezfy, Portugal

- Eeva Teräsalmi, FIP Foundation Director Immediate Past Vice President of FIP, Finland

- Allie Jo Shipman, YPG Liaison to FIP Community Pharmacy Section; Director, National Alliance of State Pharmacy Associations, USA

- Luna Elbizri, Founder and Manager, Lunapharm Pharmacy, Lebanon

- Mary Ann Kliethermes, Director of Medication Safety and Quality, American Society of Health-System Pharmacists, USA

- Daragh Connolly, ExOfficio President, Irish Pharmacy Union, Ireland

- Certina Ho, Assistant Professor; Director, Educational Program Evaluation and Scholarship; Medication Safety Advisor, Department of Psychiatry; Leslie Dan Faculty of Pharmacy; University of Toronto; Institute for Safe Medication Practices Canada (ISMP Canada)

- Mariet Eksteen, Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-T.V. Narayana, President SEAR Pharm Forum, India

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
-Raj Vaidya, Community Pharmacist, Hindu Pharmacy, India

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE)

Panellists:
-Takuya Kumamoto, Professor, Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK)-United Kingdom
-Abdulaziz khaled Alkhaledi, Member of Executive Committee, Kuwait Pharmaceutical Association, Kuwait State

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Luis Lourenço, Professional Secretary, Community Pharmacy Section, Portugal

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Charlotte Verner Rossing, Vice-chair, FIP Special Interest Group on Pharmacy Practice Research FIP, Denmark

The Høst-Madsen Medal is the highest pharmaceutical science award of FIP and it is awarded every second years. The award is named after Danish pharmaceutical scientist and former FIP president Dr Erik Høst-Madsen and is made possible with the support of the Association of Danish Pharmacies (Danmarks Apotekerforening). This year we will present the award, during a digital event, to Prof. Hideyoshi Harashima, of Hokkaido University, Japan.

The event will start with short presentations on the nanomedicine/drug delivery theme from three young researchers from different countries, after which Prof. Harashima will provide some commentary. The event will continue with the president of FIP presenting the medal and certificate to Prof. Harashima, after which Prof. Harashima will give a lecture on “Multifunctional envelope-type nano devices: From controlled intracellular trafficking to clinical application for nanomedicines”.

Participants in the event will have the opportunity to send their messages and congratulations to Prof. Harashima via the Q&A box or chatbox in Zoom.

Moderator:
- Ross McKinnon, Chair of Board of Pharmaceutical Sciences, FIP - Australia

Panellists:
- Dominique Jordan, President FIP - The Netherlands
- Hideyoshi Harashima, Professor of Pharmaceutics and chair of Laboratory of Molecular Design of Pharmaceutics, Hokkaido University - Japan
- Dr Schultz, Research Associate, University of South Australia - Australia
- Dr Yamada, Associate Professor, Hakkaido University - Japan

All three domains of pharmacy; science, education, and practice are crucial for pharmacists to solidify and expand their role in various health systems. As early-career pharmacists, we sometimes lack professional direction and well-defined opportunities in our profession. FIP is actively involved in all aspects of pharmacy practice, pharmaceutical science, and education, mostly via the work of member associations and committed volunteers.

The purpose of this webinar is to introduce early career pharmacists and pharmaceutical scientists in Bahrain to the International Pharmaceutical Federation, the Young Pharmacy Group, and the FIP Development Goals.

Join us for an interactive session to discover more about how you, as a Bahraini pharmacist, can stand in solidarity with pharmacists all over the world to advance pharmacy. **The event is also open to pharmacy students.**

Moderators:
-Farah Aqqad, FIP Regional Engagement and Project Coordinator International Pharmaceutical Federation, Jordan
-Sherly Meilianti, FIP Data and Intelligence Specialist, International Pharmaceutical Federation, Indonesia

Facilitator:
-Abrar Husaini, Volunteer Pharmacist Al Shamil Field Hospital, Bahrain

Panellists:
-Lucas Ercolin, FIP YPG Chairperson of Public Relations, PUI Health Project Manager, FIP Young Pharmacists Group (YPG), Première Urgence Internationale (PUI), Brazil
- Ikwaibom Umoiyoho, FIP YPG Chairperson of Projects, Hospital Pharmacist Zenith Medical and Kidney Center, Nigeria
- Dalia Bajis, FIP Lead for Provision and Partnerships, International Pharmaceutical Federation, Bahrain
- Lina Bader, FIP Lead for Workforce Transformation & Development, International Pharmaceutical Federation, Saudi Arabia
- Abrar Husaini, Volunteer Pharmacist, Al Shamil Field Hospital, Bahrain

Support pharmacists to play an advisory role in community pain management with OTC analgesics.

The learning objectives of this symposia involves providing community pharmacists with:

- Consumer perspectives towards their pain management
- Importance of stratifying treatment based on patient underlying conditions & needs

This session will be chaired by Lars-Åke Söderlund, President of FIP Community Pharmacy Section, Sweden.

The expert panel involves

- Pamela Kushner, MD,FAAFP, USA
- Francesco Carlo Gamaleri, B.Pharm, FPS, Italy
- John Bell, B.Pharm, FPS Australia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Prosper Hiag, Member of the Council of the FIPm President African Pharmaceutical Forum (APF), Cameroon
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain
Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Machi Hampango, Head Of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Nutrition and Dietetics, Lusaka Apex Medical University, Zambia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-John Jackson, President Western Pacific Pharmaceutical Forum, Australia
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Daniel Malone, Director of Pharmacy Education Monash University, Melbourne, Australia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay

Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima - Japan
- Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Willington Montenegro, Manager Lider Pharmacy, Ecuador

he COVID-19 pandemic has had detrimental effects on healthcare professionals and in diverse ways including physically, mentally, socially, and financially. The new and unique challenges directly associated with the COVID-19 pandemic are exacerbating an already stressful work environment for pharmacists too. Pharmacists are reporting high level of stress and burnout in practice. Hence, there is an urgent need for pharmacists to be equipped with the knowledge, tools, and resources to cope and thrive in crises. This webinar aims to provide perspectives from research and practice on the impact of workplace burnout on pharmacist mental health and highlight evidence-based supportive mechanisms and prevention tools to improve the mental health and wellbeing.  

Learning objectives:
Describe the impact of the COVID-19 pandemic on pharmacists’ wellbeing using case studies from different countries.
Discuss potential strategies to address burnout among pharmacists.
Describe the gaps in mental health education in pharmacy education.
Learn about the role of pharmacists in suicide prevention in the community.

Moderator:
-Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
-Karlee Johnston, Associate Lecturer Pharmacology Australian National University, Australia
-Aiwen Wang, Principal Clinical Pharmacist, Lecturer Singapore General Hospital (SGH), Singapore. National University of Singapore (NUS), Singapore
-Lita Chew, Group Director (Allied Health) Singhealth, Singapore
-Hayley Gorton,Senior Lecturer in Pharmacy Practice University of Huddersfield, UK

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

La reticencia a las vacunas fue considerada como una de las 10 principales amenazas para la salud mundial en 2019 por la OMS. La reticencia es uno de los principales factores que impactan en la tasa de cobertura vacunal. La información veraz y rigurosa es una herramienta crucial para combatir la actual infodemia a la que nos enfrentamos. La comunicación directa con los pacientes es una oportunidad clave para que los farmacéuticos desbloqueen los posibles temores a las vacunas y proporcionen mensajes claros y basados en la evidencia para apoyar la adopción de las vacunas. En este evento se presentan estrategias basadas en la evidencia para desarrollar intervenciones dirigidas por los farmacéuticos que se centran en la comunicación con los pacientes con el fin de fomentar la confianza en las vacunas y mejorar su aceptación.

Objetivos de aprendizaje

- Comprender los temores sobre las vacunas a nivel individual

- Discutir posibles herramientas para los farmacéuticos en la construcción de una conversación efectiva .

- Comprender los esfuerzos concretos en las farmacias comunitarias para la promoción de la vacunación a través de estrategias de comunicación eficaces

The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.

Often “one-size-fits-all” vaccine promotion efforts can backfire when they are presented to individuals who are already sceptical of vaccines. This event will outline evidence-based strategies for developing pharmacist-led interventions which focus on communication with patients in order to build vaccine confidence and improve uptake.

This event will be offred in Eglish with live translation in Spanish and French. 

Learning Objectives:
Understanding vaccine hesitancy and common reasons behind hesitancy; and
Building effective conversation through evidence-based tools.

Moderator:
-Boyan Todorov, President of the FIP Health and Medicines Information Section, President of the FIP Health and Medicines Information Section FIP, Switzerland
Panellists:
- Helen Petousis-Harris, Associate Professor and Vaccinologist University of Auckland, New Zealand
- Amy Chan, Global Lead – Workforce Transformation, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit, University of Auckland, and Auckland District Health Board, New Zealand
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists, Spain

L'Organisation mondiale de la Santé a classé l'hésitation vaccinale parmi les 10 principales menaces pour la santé mondiale en 2019. Les récentes épidémies de maladies évitables par la vaccination dans de nombreux pays à revenus élevés et l’ampleur de la désinformation au sujet des vaccins récemment approuvés contre la COVID-19 témoignent de cette menace. La réticence est l'un des principaux facteurs qui influent sur les taux de couverture vaccinale. Une information véridique et rigoureuse est un outil essentiel pour lutter contre l'infodémie actuelle à laquelle nous sommes confrontés. La communication directe avec les patients est une occasion clé pour les pharmaciens de révéler les craintes potentielles liées aux vaccins et de fournir des messages clairs, fondés sur des preuves, pour soutenir l'adoption des vaccins. Cet événement présente des stratégies fondées sur des données probantes pour développer des interventions dirigées par des pharmaciens et axées sur la communication avec les patients afin de renforcer la confiance dans les vaccins et d'améliorer leur utilisation.

Objectifs d'apprentissage

- Comprendre les craintes que suscitent les vaccins au niveau individuel.

- Discutez des outils possibles pour les pharmaciens afin d'établir une conversation efficace.

- Comprendre les efforts concrets des pharmacies communautaires pour promouvoir la vaccination par des stratégies de communication efficaces.

There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium will mark the United Nations' International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.

learning objectives:
- Identify prevailing barriers limiting the deployment of services to reduce the impact of air pollution by community pharmacists.
- Describe facilitators and enablers that can influence air pollution service delivery by community pharmacists.
- Understand the policy and regulatory landscape that needs to be established to promote air pollution mitigation services by community pharmacists.

Moderator:
- Lars-Åke Söderlund, President, Community Pharmacy Section FIP, Sweden

Panellists:
-Ema Paulino, Professional Secretary FIP, Portugal 
-Paul Sinclair, Chair of the Board of Pharmaceutical Practice FIP, Australia
-Deana Lykins, Policy & Government Affairs Consultant The Clean Breathing Institute, USA
-Anna Murphy, Consultant Respiratory Pharmacist
University Hospitals of Leicester NHS Trust, United Kingdom
-Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association (KNMP), The Netherlands

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. Supporting patients in adequately managing pain and using medicines to alleviate it in an optimal way is a common and important part of pharmacists’ daily practice.

A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Contemporary lifestyles and ways of working – especially at such challenging times as we are experiencing in many parts of the world, with lockdowns and confinements – lead to increased stress, increased use of technology and screen time, and often a lack of good sleep, which all frequently lead to headaches.

Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning Objectives:
1. Provide an understanding of 21st century headaches and their impact on patient health and wellbeing.
2. Highlight patients’ expectations from pharmacists in addressing headaches.
3. Demonstrate the role that pharmacists can play in enabling self-care of headaches.

Moderator:
- Prof. Parisa Aslani, FIP Vice President - Australia

Panellist:
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK) - United Kingdom
- Kerrie Smyres, writer and patient advocate, “The Daily Headache” - USA
- Ema Paulino, FIP Professional Secretary - Portugal

A fájdalom számos betegség tünete lehet, intenzitása pedig az enyhe kényelmetlenséget okozó panasztól a munkaképtelenséghez vezető fájdalomérzetig terjedhet. A betegek segítése a fájdalom megfelelő enyhítésében fontos gyógyszerészi feladat.

Fejfájás esetén a betegek gyakran fordulnak tanácsért a gyógyszerészekhez és nem ritkán vény nélkül kapható szereket alkalmaznak az öngyógyszerelés részeként. A modern életmód és munkakörülmények - különösen a Covid-19-járvánnyal kapcsolatos lezárások kapcsán - fokozott stresszhez, a képernyők előtt eltöltött idő növekedéséhez, az alvásminőség romlásához, és végső soron gyakran fejfájáshoz vezetnek.

A fejfájás enyhítése és a munkaképesség visszanyerése fontos a betegek jóléte szempontjából, és a gyógyszerészeknek fontos szerepe van az ennek elérését szolgáló stratégiákkal és kezelési lehetőségekkel kapcsolatos tanácsadásban.

A webinárium céljai:

1. A 21. századi fejfájás és a betegek egészségére és jólétére gyakorolt hatásainak bemutatása

2. A betegek gyógyszerészekkel kapcsolatos elvárásainak bemutatása a fejfájás kezelésével kapcsolatban

3. A gyógyszerészek szerepének bemutatása a fejfájással kapcsolatos öngondoskodásban

Self-care can empower consumers by giving them the knowledge and tools to improve the quality of their daily lives. For example, consumers often treat minor symptoms, such as a mild headache or a cold, themselves using products purchased over-the-counter at a local pharmacy or grocery store.

In 1998, a special working group of the World Health Organization (WHO) offered an inclusive definition of self-care: “Self-care in health refers to the activities individuals, families and communities undertake with the intention of enhancing health, preventing disease, limiting illness, and restoring health. These activities are derived from knowledge and skills from the pool of both professional and lay experience. They are undertaken by lay people on their own behalf, either separately or in participative collaboration with professionals.”

In today’s rapidly changing healthcare environment, self-care should be recognised as an integral element of a coordinated and comprehensive national health policy.

Self-care is a lifelong habit and culture that includes:

• Actions by individuals to stay healthy and take care of minor and long-term conditions;
• Making healthy lifestyle choices;
• Using medicines (both prescription and non-prescription) responsibly; and
• Recognising symptoms — and assessing and addressing these, if necessary, in partnership with a healthcare professional (not necessarily a doctor).

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Austen El-Osta, Director, Self-Care Academic Research Unit (SCARU) Imperial College London, UK
- Donna Castle, Executive Director of Policy and Communications, PAGB, the consumer healthcare association, UK
- Bidhata Khatri, FIP Health and Medicines Information Section Secretary, India

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Moderator:
- Andreia Bruno-Tomé, Global Lead for DG 5 - Competency Development, Senior Consultant
Independent, Portugal

Panellists:
- Ian Coombes, Member FIPED, Director of Pharmacy, Royal Brisbane and Women’s Hospital, Queensland, + School of Pharmacy, University of Queensland, Australia
- Asmaa Al-Haqan, DG2 Lead / WDH, Clinical Instructor, Kuwait University - Kuwait
- Franciscus Cahyo KRISTIANTO, WDH-DG2 Lead, Lecturer, University of Surabaya, Indonesia
- Belma Pehlivanović, YPG FIP Liaison / FIP WiSE Remote Volunteer, Teaching and Researching Assistant
Faculty of Pharmacy University of Sarajevo, Bosnia and Herzegovina
- Anisha Sandhu, Assistant Lecturer School of Pharmacy, Monash University Malaysia, Malaysia

Opioids have been successfully utilised in the management of pain. However, when not managed adequately, there is a risk they may lead to addiction and abuse among patients, with dramatic consequences in clinical and social terms. One consequence of this is the rise in cases of opioid-related overdose and deaths experienced in several countries. As medicine experts and an essential part of the healthcare team, pharmacists can support in addressing the overuse of opioids. This webinar aims to outline how pharmacists can optimise opioid use for improved patient outcomes.


Learning objectives
 At the end of the webinar, participants will:
1. Describe how pharmacists can enable the responsible use of opioid analgesics for chronic pain management
2. Identify opioid stewardship practices that can be adopted by pharmacists in the hospital settings
3. Explain the role that pharmacists can play in addressing the opioids overuse crisis
4. Recognize how pharmacists can contribute to opioid deprescribing and inappropriate pain relief

Moderator:
- Parisa Aslani, Co-chair of the working group on Patient Safety, University of Sydney, Australia

Panellists:
- Paul Glare, Chair of Pain Medicine and Director of the Pain Management Research Institute (PMRI) Northern Clinical School, School of Medicine, Faculty of Medicine & Health, University of Sydney, Australia
- Jonathan Penm, Assistant Secretary, Hospital Pharmacy Section FIP, Australia
- Sri Suryawati, Head, Division of Clinical Pharmacology and Medicine Policy, Department of Pharmacology and Therapeutics, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University. Indonesia - Yogyakarta
- Daniel Zlott, PharmD, BCOP Senior Vice President, Education & Business Development American Pharmacists Association, United States

Reconsidering your career or trapped in a job you hate? Often one is faced with a choice to change career paths and find more satisfaction and meaning in your work.
However, in moments of burnout and dissatisfaction at work, the grass often looks greener on the other side. But is it? Career change is a decision that should be made with sobriety. This digital event will provide the details on strategies for successfully switching from one area of practice to a different one of interest, while addressing difficulties that often arise when young pharmacists seek to explore new career paths.

Learning outcomes:
By the end of the webinar, participants will be able.
1. To identify and analyze one’s reasons for career change.
2. To identify and select the right career henceforth.
3. To identify one’s skills and compatibilities in the career choice made.
4. To identify one’s interests and how they affect career choices
5. To identify one’s values and how they affect career change
6. Renumeration and its impact on career decisions.

Moderator:
- Anisha Sandhu, Assistant Lecturer, Monash University - Malaysia

Co-Moderator:
- Otuto Amarauche CHUKWU, Co-founder/Research Lead, Medchain Solutions - Nigeria

Panellists:
- Brian Cicali, Vice-Chair of New Generation of Pharmaceutical Sciences (NGPS) SIG; Ruffolo Graduate Education and Research Fellow, University of Florida, College of Pharmacy - USA
- Jass Liew, Head of Medical & Technical Affairs, ASEAN and ANZ, P&G Health, Regional lead, Vitamins, Minerals and Supplements, AMA, Procter & Gamble - Malaysia
- Phaik Yeong Cheah, Head of Bioethics & Engagement, Mahidol Oxford Tropical Medicine Research Unit, University of Oxford - Thailand and UK

This event is for hospital and health-system pharmacists and leaders to review best practices for advanced and specialist pharmacist development in the hospital setting. Content will include information about the European Association of Hospital Pharmacists (EAHP) Position Paper on Hospital Pharmacy Specialisation and the FIP Hospital Pharmacy Section Basel Statements in relation to the future of clinical pharmacy practice.

Learning objectives:
a. Have an increased awareness of the competencies required of a hospital pharmacist
b. Understand global initiatives in progression and recognition pathways for advanced practice and specialisation
c. Identify resources available for use of the FIP HPS Basel Statements in the hospital pharmacy advanced practice
d. Identify new competencies that hospital pharmacists will need in the future

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, Saudi Arabia

Panellists:
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP), Hungary (home country), Belgium (country in which EAHP is based in)
- Kirstie Galbraith, Associate Director, Workforce Development Hub, Global Lead, Advanced and Speciality practice (DG4), Workforce Development Hub, Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University - Australia
- Josep Maria Guiu Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia - Spain

For students and early career pharmacists or pharmaceutical scientists, it can be difficult to know where to find support and guidance when considering professional development and career trajectory.

This FIP YPG webinar seeks to introduce young pharmacists and pharmaceutical scientists to both the Young Pharmacists’ Group and the International Pharmaceutical Students’ Federation as professional organizations that can offer many benefits to their members.

The learning outcomes include:
1. Attendees will gain insights about the organizational structure of FIP, YPG, and IPSF.
2. Learn about networking and volunteer opportunities of these organizations.
3. Learn about the benefits of membership in these organizations.
4. Hear first-hand accounts of how membership in these organizations has impacted members.

Chair:
- Louisa Sullivan, Clinical Pharmacist, University of Washington Medical Center - USA

Co-moderator:
- João Guedes, IPSF President 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Portugal

Panellists:
- Renly Lim, Research Fellow, University of South Australia - Australia
- Ikwaibom Umoiyoho, Hospital Pharmacist, Zenith Medical and Kidney Center - Nigeria
- Safiye Çağansel, Pharmacist In Charge, Treasurer & FIP Liaison, Safiye Çağansel Eczanesi, Cyprus Turkish Pharmacists’ Association - Cyprus
- Oussama MADADI, IPSF President-Elect 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Algeria
- Karima BENNARA, Chairperson of Pharmacy Education 20-21, International Pharmaceutical Students’ Federation (IPSF) - Algeria

This event will have a focus on the issues around health literacy and access to information. The societal influences on the ‘’infodemic’’ will be laid out, also the role of health care professionals, health workers and be vaccine hesitant people. We will consider all the policy elements that need to be addressed to overcome this, identifying tools to overcome these issues from a range of angles and the role pharmacy can play.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

This event will be moderated by Professor Timothy Chen, President of the Social and Administrative Pharmacy Section at FIP and the Head of Pharmacy Practice and Health Services Research at The University of Sydney.

Moderator:
Timothy F Chen, Head of Pharmacy Practice and Health Services Research, The University of Sydney

Speakers:
• Mujahidhussein G Valji - Chief Pharmacist, Aga Khan Health Services, Tanzania
• Dr. Régis Vaillancourt - Pharmacy Consultant, Canada
• Dr. Fiona Stanaway - Senior Lecturer in Clinical Epidemiology, School of Public Health, University of Health, Australia
• Hannelie Meyer - Professor in the School of Pharmacy, Sefako Makgatho Health Sciences University, and Head of the South African Vaccination and Immunisation Centre (SAVIC)

Watch the recording the first day here. 

This event  explores FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

During this two days event we’ll explore transformation of pharmacy practice toward patient care during COVID-19 pandemic 

This event will also explore FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

More info here. 

With the publication of the document FIP Vector-Borne Diseases: A Handbook for Pharmacists, produced in collaboration with the Pharmaceutical Forum of the Americas (PFA), the International Pharmaceutical Federation (FIP) offers an overview of these pathologies and notes that pharmacists are uniquely positioned to help communities and patients protect themselves from them. This webinar will describe the most prevalent vector-borne diseases in the Southeast Asian region; subsequently, the pharmaceutical interventions that this professional can carry out will be identified and finally the experiences developed by the SEAR Pham Forum regarding the pharmaceutical approach to Vector Borne diseases will be presented.

1) Recognize the main concepts related to vector-borne diseases.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region of the Southeast Asia.
3) Determine the activities that the pharmacist can develop from the pharmacy for the prevention, detection, control, and management of pharmacotherapy of vector-borne diseases.
4) Identify the experiences developed by the SEAR Pham Forum to support the actions of pharmacists in the fight against diseases transmitted by vectors

Moderator:
-T.V. Narayana, President, SEAR Pharm Forum, President Indian Pharmaceutical Association - India
Facilitator:
-Manisha Shridhar, Regional Advisor, IPR, Trade&Health, WHO-SEARO - India

Speakers:
- Manjiri Gharat, FIP Vice-President, Vice-President of Indian Pharmaceutical Association (IPA) and Chairperson of IPA Comm.Ph.Division; Executive Committee Member, SEARPharm Forum of FIP and WHO; Principal K. M. Kundnani Pharmacy - India
- Chinta Abayawardana, FIP Members Organization/ Individual Member, General Secretary Pharmaceutical Society of Sri Lanka - Sri Lanka
- David C. Yohanes, Clinical Pharmacist Clinical pharmacist in Bandung Hospital - Indonesia
- Yagya Prasad Neupane, Ex-Chairmen Nepal Pharmacy Council -Nepal

Episode 11 of the FIP Development Goals Digital Programme is focused on “advancing integrated services”. The goal visualizes a people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered professional services. Through the lenses of pharmaceutical sciences, workforce, education, and practice, this event aims to advance the ideals of integrated service delivery in a way that benefits our patients and lead to improvement of health outcomes.

Event outcomes:
1. Describe and explain the components of FIP DG 7 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 7 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 7
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
- Mariet Eksteen, Global Lead for Advancing Integrated Services (DG 7) FIP - South Africa

Panellists:
- Bob Buckham, National Programme Manager – Integrated Community Pharmacy Services Central Technical Advisory Services (TAS) - New Zealand
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services Lecturer, University of Bremen -
Germany
- Lars-Åke Söderlund, President, the Community Pharmacy Section, FIP Co-chair, the FIP Congress Programme Committee International Pharmaceutical Federation - Sweden
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Hospital Pharmacist, Centre Hospitalier Georges Renon - France

Health systems and health care professionals are called upon to address and mitigate the impact of air pollution on people’s health and quality of life. There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. This webinar will provide examples of services that pharmacists can deliver to support better breathing.

Learning objectives:
- Describe the role that pharmacists can play in mitigating air pollution in the community.
- Identify the different tools available to pharmacists to enable the reduction of the impact of air pollution in the community.
- Understand the various arrays of services that community pharmacists can employ in supporting better breathing.

Modetaror:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden

Panellists:
- Daniella Munene, CEO Pharmaceutical Society of Kenya - Kenya
- Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association - The Netherlands
- Emilio Santoro, Medical Affairs Principal Scientist, Respiratory and Skin Health, Global Category, GSK Research & Development - United Kingdom

This event will explore latest developments in digital health that supports self-care. It will identify practical strategies to appraise latest technology and manage misinformation and the ‘infodemic’.  Current practice and role of the pharmacist in digital health is also discussed.

Aim: To discuss digital health and how to ensure it supports safe and effective self-care

Learning objectives:

1. Define digital health and explain digital health priorities (FIP Development Goal 20)

2. List ways digital health can enable self-care

3. Describe approaches to delivering safe and effective digital self-care

4. Give examples of current pharmacy practice in digital health that supports self-care

Moderator

- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Panellists:

- Timothy Aungst, Associate Professor.  Freelance Writer and Consultant, The Digital Apothecary, USA

- Peter Guthrey, Senior Pharmacist, Strategic Policy, Pharmaceutical Society of Australia, Australia

- Jan De Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium 

Episode 3 examines inequities in gender access to vaccines to inform pharmacy policy. Various angles to vaccinations and the gender will be discussed including general gender access, terms of empowering women as caregivers to support vaccinations, the impact of COVID-19 on gender inequity, and the issues around gender inequity in the workforce (which is especially important to discuss in 2020 Year of the Health Worker).

The “Role of Early Career Pharmaceutical Organisation (ECPO) in Global Health” report describes the activities related to global health undertaken by individuals and groups of pharmacists and pharmaceutical scientists from different countries. The launch event will showcase key findings from the “Global survey on the role of Early Career Pharmaceutical Organisation (ECPO) in global health”, discuss the role that youth can play in global health citing examples from different national YPGs, and discuss opportunities to advocate on the role of ECPO in global health across regions.

Learning objectives:
1. learn about the key findings from the Global survey on the role of Early Career Pharmaceutical Organisation (ECPO) in global health
2. hear from national YPG representatives from different regions about the global health-related activities they are doing in their region.
3. be able to identify areas of development in global health and opportunities to advocate for early career pharmacists and pharmaceutical scientists in their regions.

Moderator:
- Raquel Oliveira - Portugal

Panellists:
- Sherly Meilianti - Indonesia
- Lucas Ercolin - Brazil
- Deanna Mill - Australia
- Onyeka Obidiegwu - Nigeria
- Funmbi Okoya - Nigeria/US
- Renly Lim - Australia
- Anggun P Wardhani - Indonesia
- Cedric Chua Chairman - Malaysia
- Teoh Cherh Yun - Malaysia

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021.

The focus of the 10th episode in our webinar series on the FIP Development Goals is FIP DG4 (Advanced & specialist development) and the need to have a flexible, capable and competent pharmacy workforce to meet the needs of complex pharmaceutical care. Join us on 4 August at 11:00 CEST. 

Learning objectives:
1. Describe and explain the components of FIP DG 10 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 4 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 4
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderators:
-Desak Ernawati, FIP Global Lead for DG4 Advanced and specialist development, Academic & researcher Universitas Udayana-Indonesia
-Arit Udoh, FIP Global Lead for DG4 Advanced and specialist development, Senior Clinical Trial CRD/Project Manager University of Birmingham, UK

Panellists:
- Kirstie Galbraith, Assoc. Director, Workforce Development Hub; Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University- Australia
- Sylvain Grenier, MEPS President, Director, Plasma Proteins and Related Products Formulary, Canadian Blood Services - Canada
- Marilyn Morris, FIP Board of Pharmaceutical Sciences ExCo and Expert Member, SUNY Distinguished Professor, State University of New York at Buffalo, USA

Diabetic foot is a devasting complication of diabetes that can lead to loss of a limb and life. It has a complex pathology characterised by neuropathy, ischaemia and slow healing. Often the resulting loss in feeling leaves patients unable to sense the damage to their feet. 451 Million suffer with diabetes worldwide, 1 in 10 will get a foot ulcer, 80% go to have an amputation, 8 out of 10 amputations can be prevented by intervention.

Aim: is to strengthen the link of Foot Health and Diabetes and to create an interest and commitment to regular foot care for every diabetic prescription dispensed to the patient.

Target audience: Healthcare professionals – particularly the pharmacy team, who support people to self-care.

Learning Objectives:

• To describe how the pharmacy team can support self-care of feet for people with diabetes;
• Identify and educate pharmacists on regular foot checks and foot care routines 3.Discuss approaches on empowering people and pharmacists on what to ask the people with diabetes, when to refer to a specialist or GP and what to recommend as a treatment.

Programme

• Welcome (5 minutes) – Raj Vaidya, Moderator
• Supporting people with diabetes to look after their feet – pathology and common conditions (20 minutes) – Maria Mendes, National Association of Pharmacies (ANF) TBC
• The potential role of the Pharmacists in footcare of people with diabetes – footchecks and footcare routines (20 minutes) – Astrid Czock, Qualiccare
• Case study: footcare in diabetes management (20 minutes) – Luna El Bizri, Lunapharm Pharmacy
• Panel discussion – questions and answers (20 minutes) – Panel + Moderator
• Summary and close (5 minutes)- Raj Vaidya, Moderator

The World Health Organization lists vaccine hesitancy—concerns related to vaccination or outright refusal to receive vaccines despite availability—as one of the top ten threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against novel Sars-Cov-2 virus.

Often times, “one-size-fits-all” vaccine promotion efforts can backfire when presented to individuals who are already sceptical of vaccines. This event will outline evidenced-based strategies for developing pharmacy-led immunization campaigns which communicate the value of vaccines to specific patient groups in order to build vaccine confidence and improve uptake.

Delivered in English with live translation in French and Spanish languages. 

Learning Objectives:
1. Understanding vaccine hesitancy and common reasons behind hesitancy
2. Developing a robust immunization campaign: steps and essential components
3. Assessing the success of immunization campaigns and importance of continuing advocacy

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

This event will explore the evolution in our understanding of health literacy and identify practical strategies to improve health literacy in community populations.  The role of the pharmacist in health literacy is also discussed.

Health literacy describes the skills that enable individuals to obtain, understand and use information to make decisions and take actions that have an impact on health.   Several countries now have well established national strategies and plans to improve health literacy through programs to improve the skills of patients and the public, and service changes to reduce the literacy demands on patients and the public.

Aim: To discuss health literacy, how it readies the global population for self-care and how pharmacists can contribute

Learning objectives:

• Define health literacy.
• Describe different rates of health literacy around the world.
• Discuss challenges and opportunities for improving health literacy;
• Critique the role of the pharmacist in health literacy.

Programme

1. Welcome (5 minutes) – Dr Sarah Dineen-Griffin, Charles Sturt University (Moderator)
2. Importance of health literacy and how health systems can support it: a pharmacy perspective (20 minutes) – Helen Ryan, National Adult Literacy Agency (Ireland).
3. Improving health literacy (20 minutes) – Dr Anandi Law, Western University of Health Sciences (USA)
4. The role of pharmacists in supporting health literacy (20 minutes) – Greg Duncan, Monash University (Australia).
5. Panel Discussion (20 minutes) – Panel + Moderator
6. Summary and close (5 minutes) - Dr Sarah Dineen-Griffin, Charles Sturt University (Moderator)

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Western Pacific region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

1) Identify the most prevalent vector-borne diseases in the Western Pacific region.

2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.

3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderator:
John Jackson, President, Western Pacific Pharmaceutical Forum

Panellists:
- Aya Yajima, NTD focal point, Malaria and Neglected Tropical Diseases Unit, WHO Regional Office for the Western Pacific
- James Kelly, Malaria Focal Point, WHO WPRO
- Renly Lim, Research Fellow, University of South Australia, FIP YPG President
- Judilynn Solidum, Professor, University of the Philippines College of Pharmacy

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

he choice of delivery device or container closure system versus the Reference Listed Drug is a key consideration when developing a biosimilar. Can a biosimilar be developed using a different container closure system than the reference Listed Drug and if yes, how different can this container
closure system be? If the reference is in a vial or a prefilled syringe, can the biosimilar be in an autoinjector? What are additional requirements that need to be considered in order to be able to claim interchangeability.

Learning objectives:
1. we focus on requirements applicable to biosimilars when targeting the US or the EU markets.
2. we discuss acceptable differences in device-component between a biosimilar and the
reference product.
3. we address a few case studies.

Moderator:
- Mathew Cherian, Consultant - USA

Co - Moderator:
- Kaushik Desai, Advisor , Indian Pharma Machinery Manufacturers Association - India

Panellist:
- Alison Bascou, Senior Regulatory Affairs Manager, Becton- Dickinson - France

Early career Pharmacists and Pharmaceutical Scientists have to uphold professionalism by participating in sessions and workshops that offer training/certification. This webinar seeks to enlighten young pharmacists and pharmaceutical scientists on ways to develop their skills and participate in trainings that offer certification for their chosen career paths. 

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine that can result in waste and harm including avoidable hospital attendances and admissions. Hospital pharmacists can be an important part of the asthma pathway and powerful change agents. This webinar will provide updates on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from experts from the Asthma Right Care social movement about how to make impactful change happen in the provision of asthma care within secondary care settings.

By the end of this webinar participants will have:
1. Received a critical update on international asthma guidelines and the implications for hospital pharmacists
2. Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and acute care and how to use the right medicines in the right way
3. Discussed what leadership opportunities, motivation and capabilities are needed to bring about change such as improved discharge from emergency departments and respiratory wards; and shared approaches between hospital and community pharmacists.

Chair:
- Ema Paulino, Professional Secretary, FIP - Portugal
Panellist:
- Marina García-Pardo, Family physician, IbSalut, Mallorca - Spain
- Toby Capstick, Consultant Pharmacist - Respiratory Pharmacist, Leeds Teaching Hospitals NHS Trust - United Kingdom

This Pharmacy Technician Symposium is the 3rd in a series and focuses on Pharmacy Technician regulations in the context of practice, education, continuing professional development and organizations. Four Pharmacy Technicians will share their experience

Learning objectives:
1. Review recent trends in regulations that enable better patient access to care
2. Provide a quick review of literature on the topic of Pharmacy technician regulation, related to practice, education, continuing professional development and organizations
3. Understand how regulations have impacted a diverse set of global markets
4. Share global case studies of how pharmacy technician regulation positively impacts patient care in practice
5. Identify best practices in regulatory advancement that support the pharmacy technician profession preparing for the decade ahead

Moderator:
- Vijay Sarma, VP–Expert Audience Marketing, McCann Health - Canada
Co-Moderator:
- Abigail Tan Ming Li (KKH), Pharmacy Technician, KK Women's and Children's Emergency Pharmacy - Singapore

Panellists:
- Jennifer Falkenrath, Bureau Manager, Division of Occupational and Professional Licensing in the State of Utah - United States of America
- Cristiano Matos, Pharmacy Technician, Farmácia Coimbra - Portugal
- Sakhumhlanga Goci, Pharmacy Technician, Eastern Cape Department of health, Cecilia Makiwane hospital mdantsane - South Africa
- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists - Kenya

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

The attendee will learn:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralized medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Moderator:
- Ronald Guse, FIP Regulators Forum Chair, NABP - Canada

Speakers:
- Prof. Aslani Parisa, University of Sydney - Australia
- Jan Byrd, Director, Health Policy Healthcare Excellence - Canada
- Mitul Jadeja, Vigilance and Risk Management of Medicines (VRMM) Division, Medicines and Healthcare products Regulatory Agency, MHRA - UK
- Alison Reid Executive Director, International Association of Medical Regulatory Authorities (IAMRA) - Australia
- Andi Shirtcliffe, Chief Advisor - Pharmacy, Office of the Chief Medical Officer, Ministry of Health - New Zealand

This event aims to provide different perspectives on how the pandemic has impacted the scope of services provided by pharmacists in the community, hospital and clinical biology settings. In this roundtable discussion, a panel of experts in different areas will share their thoughts in which services were suspended or de-prioritised and need to be recovered or restored, and which new services emerged and may need to preserved beyond the pandemic.

Learning objectives:
1. Understand the impact of the pandemic on the scope of services pharmacists provide in the different settings
2. Discuss the priorities in the restoration or recuperation of services among different regions

Moderator:
- Robert Moss, President, Hospital Pharmacy Section, FIP - The Netherlands

Co - Moderators:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden
- Julien Fonsart, President, FIP Clinical Biology Section, FIP - France

Panellist:
- Esteban Zavaleta, Director of Pharmacy, Hospital Clínica Bíblica - Costa Rica
- Ana Paula Martins, President, Portuguese Pharmaceutical Society - Portugal
- Ismael Olmos, Head of the Pharmacy Department, Member of the Clinical Pharmacology Unit, Hospital Vilardebó - Uruguay
- Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA) - South Africa
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP)
Hungary (home country) | Belgium (country in which EAHP is based in)
- Amrahi Buang, President, Malaysian Pharmacists Society (MPS) - Malaysia
- Chris Freeman, National President, Pharmaceutical Society of Australia - Australia
- Ziad Nassour, Former President of the Lebanese Order of Pharmacists, Lebanese Order of Pharmacists - Lebanon

A Direct Application of the FIP Basel Statements on Human Resources, Training and Development & Aligned with FIP Development Goals.

Both the FIP Development Goals and the Hospital Pharmacy Section Basel Statements list the competency of the pharmacy workforce as important. In a listing of priority goals from the DG and the BS, FIP members identify competency goals as a top priority. The HPS Vice Presidents also list competency as a high priority for advancing hospital pharmacy practice. The webinar will address curricula and ongoing continuing education to provide students and practitioners with the necessary knowledge and skills for contemporary hospital pharmacy services.

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences, University of Cincinnati - USA

Panellist:
- Daniel Kibuule, Associate Dean, - Hage Geingob Campus, University of Namibia - Namibia
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd., H-8/4, Islamabad - Pakistan

Episode 2 takes a life-course approach to discussing vaccination. The panelists will focus on age and explore vaccines equity and access through life’s ages and stages – from childhood (including pregnancy) to later adulthood – from a pharmacy perspective. They will focus on setting out the policy issues and immediate next steps, determining what pharmacy needs to do to singularly affect the most change in this area.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

About this series – The first of the two series comprises 5 episodes which include the opening event alongside 4 other events which explore equity in vaccinations across the different angles of age, gender, literacy & education, and interprofessional unity & collaboration.

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, FIP

Guest:
- Jane Barratt, Secretary-General International Federation on Ageing

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021.

Episode 8 of the FIP Development Goals Digital Programme has as a focus – people-centred care. The goal visualizes collaborative interprofessional strategies and people-centred professional services to support the prevention, screening, clinical management, and therapeutic optimisation of non-communicable diseases (NCDs) and long-terms conditions (LTCs). Hence, the event will seek to amplify how pharmaceutical education, workforce, practice and sciences can be integrated to ensure pharmacists’ contribution to the prevention and management of NCDs.

Learning objectives:
1. Describe and explain the components of FIP DG 15 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 15 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 15
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, FIP - Spain

Panellists:
- Astrid Czock, CEO, QualiCCare - Switzerland
- Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance - Switzerland
- Aniekan Ekpenyong, Practice Transformation Projects, Coordinator, FIP - Nigeria
- Isabel Jacinto, Executive Director, Graduate School of Health and Management (EPGSG), National Association of Pharmacies (ANF) - Portugal
- Yu-Chieh (Jack) Chen, Secretary General, Taiwan Society of Health-System Pharmacists - Chaina Taiwan

As the global population continues to age, pharmacists' role in long term care and retirement homes will become increasingly more crucial. During the COVID-19 pandemic, with older persons being particularly vulnerable to the most severe forms of the disease, and often isolated from their families and loved ones, the care provided by long-term care facilities became all the more important to preserve health and well-being and prevent disease. This also raised the need to discuss the future role that pharmacists may play in supporting care and medication management in these facilities and to this particular population group.

1) Understanding the role that pharmacists play in medicine optimisation and reduction of medication-related harm in long-term care facilities
2) Understand the impact of the pandemic on the role of the pharmacists in long-term care
3) Discuss multidisciplinary synergies in the context of long-term care facilities
4) Identify changes in organisational culture of reducing psychotropic prescribing in long-term care facilities

Moderator:
-Robert Moss, President Hospital Pharmacy Section of the International Federation of Pharmacists, The Netherlands

Panellists:
- Tim Chen, President FIP Social and Administrative Pharmacy Section, Australia
- Anisa Shivji, Founder and CEO, RxVisit and Long term care expert, Canada
- Hui-Chen Su, Director Taiwan Society of Health-System Pharmacists (TSHP), China Taiwan
- Mouna Sawan, Researcher Centre for Medicine Use and Safety, Monash University Research Fellow, Australia

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine. Community pharmacy can be an important part of the asthma pathway and powerful change agents. This webinar will update on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from community pharmacists in the Asthma Right Care social movement about how to have impactful conversations about personal, national and international change and how to make it happen.


By the end of this webinar participants will have:
-Received a critical update on international asthma guidelines and the implications for pharmacists
-Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and how to use the right medicines in the right way
-Discussed what opportunities, motivation and capabilities are needed to bring about change.

Moderator:
- Ema Paulino, General Manager Ezfy, Portugal

Panellists:
- Francesc Moranta Ribas, Community Pharmacist, Farmacia Sanz Guiilén, Spain
-Darush Attar-Zadeh, Respiratory Lead Pharmacist, Community Pharmacy Locum Independent Prescriber, Cross Chemist North Central London Clinical Commissioning Group, UK
-Debbie Rigby, Director, Pharmeducation Clinical Associate Professor, Queensland University of Technology, Brisbane, Australia

The “FIP UNITWIN Pathfinder Toolkit” is a step-by-step guide to support the global expansion of the FIP-UNESCO UNITWIN programme. It will also support academic institutions across Africa to establish an Africa-wide association of schools of pharmacy, with the leadership of African Pharmaceutical Forum and building on the experiences of similar associations around the world.

At the end of this session, participants will:

1. Learn about the FIP-UNESCO UNITWIN Programme and the value of educational partnerships
2. Share expressions of interest to join new FIP-UNESCO UNITWIN centres for excellence at their regions
3. Discuss the way forward for the establishment of an African-wide association of schools of pharmacy

Moderators:
-Ralph Altiere, Dean and Prof. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
-Prosper Hiag, President African Pharmaceutical Forum,
Cameroon

Panellists:
-Nilhan Uzman, FIP UNITWIN Programme Lead, FIP Lead for Education Policy and Implementation, The Netherlands
- Anne H Anderson, Vice Chair UK National Commission for UNESCO, UK
- Alison Ubong Etukakpan, FIP Educational Partnerships Coordinator, Nigeria
-Wanda Maldonado, Dean & Representative University of Puerto Rico & COIFFA, Puerto Rico, USA
-Cyril Usifoh, Prof. and former Dean University of Benin, Nigeria
- Yahya E. Choonara, Prof. and Head of the Dep. of Pharmacy and Pharmacology, University of the Witwatersrand, South Africa
-Chiluba Mwila, Lecturer & Research University of Zambia, Zambia
-Gisèle Étamé, Head of Department of Pharmaceutical Sciences University of Douala, Cameroon
- Aysu Selcuk, Lecturer Ankara University, Turkey
- Khalid Garba Mohammed, Lecturer Bayero University, Nigeria
-Arinola E. Joda, Head of Clinical Pharmacy and Biopharmacy Department, University of Lagos, Nigeria
-Reda Djidjik, President & Prof. Algerian Federation of Pharmacy, Algeria

Aim:
To identify how the community pharmacy team can support self-care for people with musculoskeletal pain

Learning objectives:
1. List the signs and symptoms of musculoskeletal pain;
2. Describe how to support people with musculoskeletal pain
3. Discuss appropriate management in the choice of medicines.

Moderator:
- Luis Lourenço, FIP Professional Secretary, Community Pharmacy Section, Portugal

Panellists:
- Laura Murphy, Pharmacy Clinical Leader and Clinical, University Health Network - Canada
- Philip Conaghan Director of the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, - UK
- Hilary McKee, Consultant Pharmacist Northern Health and Social Care Trust, UK

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. As such, FIP considers that it is essential to promote dialogue and understanding around these perceptions among healthcare professionals’ organisations at the international level, so that these can be cascaded to the regional, country and local levels.
After this webinar the participants should have a better understanding of the following topics:
1. The role of the various health professions in contributing to increased vaccination coverage
2. Drivers and barriers to diversifying vaccination pathways and providers.
3. Possible actions by the different health professions in addressing vaccine hesitancy and complacency.
4. Collaboration and autonomy of the various healthcare professionals in delivering vaccinations.

Moderator:
Jane Barratt, Secretary-General International Federation on Ageing

Panellists:
-David O. Barbe, President World Medical Association
-Howard Catton, Chief Executive Officer International Council of Nurses
- Jonathon Kruger, CEO World Physiotherapy
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP)
- Enzo Bondioni, Executive Director, FDI World Dental Federation

The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.

Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students. 

This workshop aims at presenting the state-of-art of systematic reviews and meta-analyses in the biomedical field. An overview of the main changes of the new PRISMA statement (2020) compared to the previous version (2009) is provided. Our role as researchers and healthcare professionals in enhancing science reliability is also discussed.

This workshop aims at providing an overview on current trends in medication adherence research. Methos for assessing medication adherence are described. The evidence on interventions for managing medication adherence is reviewed. Finally, innovative approaches in this field of research are discussed. 

This webinar will present selected findings from a recent FIP survey on the regulation of the distribution of medicines and pharmacists’ role in supporting responsible self-care. It will also focus on the role of pharmacies in relation to the use of generics, as well as alternative and complementary medicines.

Learning objectives:
1: Awareness of the importance of the community pharmacists’ role in self-care
2: Identify key aspects of the pharmacist’s action in empowering patients for self care
3: Demonstrate possible positions of the pharmacist in the recommendation of alternative and complementary medicines

Moderator:
- Ronald Guse, Chair, FIP Regulators Forum- USA/Canada

Facilitator:
- Rúben Viegas, FIP Practice Development Projects Coordinator - Spain

Panellists:
- Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation - Spain
- Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University - Australia
- Magaly Rodríguez de Bittner, PharmD, FAPhA, FNAP, Associate Dean of Clinical Services and Practice Transformation and Vice-President Forum of the Americas, University of Maryland School of Pharmacy - USA
- Benjamin K. Botwe, President, Pharmaceutical Society of Ghana - Ghana

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Eastern Mediterranean region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1) Identify the most prevalent vector-borne diseases in the Eastern Mediterranean region.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.
3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderators:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University - United Arab Emirates (UAE)
- Wael Ali, President, President Egyptian organization of pharmacy. (EOP) - Egypt

Panellists:
- Rula Darwish, Professor, University of Jordan, Jordan
- Sherif Kamal, Director of pharmaceutical services, Children’s Cancer Hospital- Egypt
- Nidhal Marie, Prof Dr in the School of Pharmacy, Almustansirya University-Iraq - Iraq
- Yousif Adam Ahmed Sabeel, Director, Planning and Policy Department, National Medical Supplies Fund - Sudan

Episode 1, the digital programme’s Opening Event, will set the stage for the entire programme. Together we will revisit the key outcomes of the Transforming Vaccination 2020 programme, specifically focusing on the outcomes relating to shaping policy around equity, access and sustainability and how they are shaping the FIP vaccination agenda for 2021. We will also describe this year’s programme, outline its key aims and objectives as well as outcomes. This special programme opener is for anyone invested in transforming and shaping vaccination in pharmacy!

Moderators:
- Lina Bader, Lead for Workforce Transformation & Development, International Pharmaceutical Federation -Saudi Arabia
- Farah Aqqad, Regional Engagement and Project Coordinator International Pharmaceutical Federation (FIP) - Jordan

Panellists:
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP) - The Netherlands
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation International Pharmaceutical
Federation (FIP) - Spain
- G. Sumalatha, Executive Committee Member SEARPharm Forum - India
- Prosper Hiag, President African Pharmaceutical Forum (APF) - Cameroon
- John Jackson, President Western Pacific Pharmaceutical Forum - Australia
- Nadia Al Mazrouei, President EMROPharm Forum, Academic &Healthcare consultant - UAE

This event will showcase current self-care delivery in community pharmacy across the globe and explore how future delivery could look. People centred care is at the heart of self-care and so this is an important area to explore including the associated communication skills. Strategies to build trust and rapport is vital to self-care will also be discussed. This topic is important because pharmacy teams are increasingly supporting patients with self-care.

Aim:
Explain current and future practice with delivering people centred self-care.

Learning objectives:
1. Summarise current practice of self-care delivery;
2. Propose future practice of self-care delivery;
3. Define people centred care;
4. List the communication skills required for people-centred care;
5. Discuss how to build trust and rapport to deliver self-care.

Moderator:
Sari Westermarck, Proprietary Pharmacist (Finland)

Speakers:
Alistair Bursey, New Brunswick College of Pharmacists, Canada.
David Skinner, President, International Self-care Foundation
Parisa Aslani, Professor of Medicines Use Optimisation, University of Sydney, Australia.
Betty Chaar, Associate Professor, University of Sydney, Australia

Air pollution needs to be addressed urgently and not only as an environmental and ecological threat, but also as a direct threat to health. This webinar will describe the multiple ways in which air pollution can be harmful to health. Understanding such impacts is essential so that professional services and interventions by pharmacists can be developed to address this global threat.

Learning objectives:
- Identify the various ways that outdoor and indoor air pollution impacts on human health
- Understand the short-term and long-term impact of air pollution on health
- Illustrate how air pollution might change the type of professional services offered by pharmacists
- Describe the different roles pharmacists can play in addressing air pollution

Moderator:
Prof. Rula Darwish, University of Jordan - Jordan

Panellists:
Prof. Gary WK Wong, Professor and honorary consultant, Department of Paediatrics Chinese University of Hong Kong - Hong Kong
Prof. Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College - UK

The FIP YPG mentorship programme which is currently on the first cycle aims to provide guidance for young pharmacists and pharmaceutical scientists who are developing their career.
The webinar will focus on educating young pharmacists and pharmaceutical scientists on how to effectively utilize the GROW model as a way to develop their skills and expertise in mentorship and it is an excerpt from the career development toolkit for early career pharmacists and pharmaceutical scientists. There will also be a panel session where the participants will have the opportunity to interact with panelists; the panel will include the main speaker, two mentors and two mentees. The aim of the Panel session is to provide participants with practical examples of how mentorship works and provide feedback on the current FIP YPG mentorship cycle.

The learning outcomes for the webinar include:
· Participants will be introduced to the FIP YPG mentorship program.
· Participants will learn about the GROW model and how it can be effectively linked to mentorship.
· Participants will get feedback and real-life testimonials from mentors and mentees in the ongoing cycle of the FIP YPG mentorship programme.
· Participants will also gain insights on the important attributes to consider for, when selecting mentors in their desired area of practice.

Moderator:
- Benjamin Wong, Lead Digital Health Record Analyst, Government ACT - Australia
Main speaker:
- Margarita Gutierrez, Assistant Professor 5, University of the Philippines- Manila College of Pharmacy - Philippines
Panellists:
- Charlotte Verner Rossing, Director of Research and Development at Pharmakon, The Danish College of Pharmacy practice - Denmark
- Miranda Sertić, Ass. Professor, University of Zagreb Faculty of Pharmacy and Biochemistry - Croatia
- Aulia Hanifah Fadlol, Business Development at GoApotik, PT. Global Urban Esensial / University of Indonesia - Indonesia
- Emine Merve Yıldırım, Pharmacy Student - Turkey

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

FIP Development Goal 21 “Sustainability in pharmacy” is not only about ensuring sustainable services in practice and all that this encompasses, but also covers the impact of pharmacy and pharmaceuticals on the environment. In this event, we explore sustainability in pharmacy from the perspectives of workforce & education, science, as well as practice – and we will showcase the strategies, tools and resources of FIP on this Goal. The event features a global panel of pharmacy experts and is co-chaired by FIP CEO Dr Catherine Duggan.

Event outcomes:
1. Describe the FIP Development Goals and explain the components of DG 21 (and its three elements: workforce & education, science, and practice)

2.Showcase the FIP tools, evidence, and resources to support DG 21 implementation across the three elements.

3. Identify priorities across practice, science, and workforce & education within DG 21

4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Catherine Duggan, CEO - FIP, The Netherlands
Co-moderator:
Lina Bader, FIP Lead for Workforce Transformation & Development, Saudi Arabia

Panelists':
Eeva Teräsalmi, FIP Vice President, Finland
Susan James, Director of quality at Ontario College of Pharmacists, Canada
Saja Alnahar, Assistant Professor Yarmouk University - Jordan
Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay
Manjiri Gharat, Vice-President Indian Pharmaceutical Association, India

Dissolution testing is an important physiochemical test for the development of solid oral dosage forms. As a quality control test, the dissolution test is used for assessment of drug product quality and is specified for batch release and regulatory stability studies. In vitro dissolution test results
can often be correlated with the biopharmaceutical behavior of a product. This webinar provides a summary
of views from major global agencies (Europe, Japan, United States), pharmacopoeias, academia, and
industry. Based on available guidance and literature, this webinar summarizes highlights for development
and validation of a suitable dissolution method, setting appropriate specification.
Clarify the importance of dissolution testing within the pharmaceutical lifecycle.
Learning objectives:
• Understand the concept of Dissolution Testing
• Learn which parameters are relevant for the development of a dissolution method
• Learn how to validate the dissolution method
• Learn how to set suitable specifications

Moderator:
Jobst Limberg, Head of Unit Scientific Quality in European Procedures, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) - Germany

Panellist:
Horst-Dieter Friedel, Former Director, Former Bayer AG - Germany

In this interactive session, faculty members and students, will share their past year’s experience with remote and online pharmacy education. Through pre- and in-session polling, we’ll share and discuss what we wish we knew one year ago, what we know now, and what we’d still like to know. Topics will be audience-driven, in the themes of educational methods, faculty support, student views, regional differences and others. The session's learnings will allow us to build future offerings, meeting members' needs.
Learning objectives:
At the end of this session, all participants (faculty members and students from all regions) will be able to:
- Participate in the sharing, assessment and discussion of global perspectives on remote and online learning, through pre- and in-session polling;
- Share and discuss their past year’s remote and online education and assessment experience, noting tips, challenges and rewards, and remaining questions;
- Provide innovative ideas to improve remote and online pharmacy education based on experience of the past year and goals for the future.

Moderators:
-Shaun Gleason, University of Colorado, USA
-Carl Schneider, University of Sydney, Australia
Panellists:
-Vivienne Mak, Monash University, Australia
-Sarah Scoular, University of Colorado Skaggs School of Pharmacy, USA
-Rebekah Moles, University of Sydney - Australia
-Claire Anderson, Division of Pharmacy Practice, UK
-Younes Karodeh, Howard University, USA
-Jamila Jorden, Howard University, USA
-Daniel Moraga, University of Valparaiso, Chile
-Emmanuella Nzeribe, Tamale Teaching Hospital, Ghana
-Priscilla Owusu-Mensah, Student, Kwame Nkrumah University, Ghana
-Ikwaibom Umoiyoho, Hospital Pharmacist, Nigeria
-LaMarcus Wingate, Howard University - USA
- Patricia Acuna, Faculty of Pharmacy. U. Valparaiso - Chile

This webinar will focus on the the role of community of pharmacists in weight management and obesity prevention, screening, referral and management, pharmacy-led weight management approaches and the intergenerational correlations in hypercholesterolemia and obesity. In addition, we will also present selected aspects from the  FIP handbook on nutrition and weight management for pharmacists, to be launched that day.

Learning objectives:
- Understand the role of community of pharmacists in obesity and weight management prevention, screening and referral
- Discuss the importance of prevention and management of childhood obesity
- Share good practices in terms of community pharmacy services focusing on weight management

Moderator:
Leonila Ocampo, ExCo member Community Pharmacy Section - Philippines

Panellists:
- Lauren Blum, Global engagement fellow, UNC Eshelman School of Pharmacy - USA
- Irene Um, Lecturer, School of Pharmacy, University of Sydney - Australia
- Adela Martin, Member of the Board of Directors and Research Support Officer, Spanish Society of Clinical, Healthcare and Community Pharmacy (SEFAC) - Spain
- Jorge Robledo, Director of the Interinstitutional Prevention and Health Education Program - Argentina

During the COVID-19 pandemic the scientific community has united in the common strive to find the facts needed to fight the virus. Early in the pandemic there was a great push towards drug repurposing to find ways of treating those affected by the virus. Lately we have seen great advancements with vaccines helping to prevent the development of severe effects. In this webinar we will see two case studies: the repurposing of remdesivir and the development of an mRNA-based vaccine.

learning objectives:
In this webinar the participants will:
1. gain a better understanding of repurposing of remdesivir and the effectiveness of this treatment
2. learn about the development of mRNA vaccines utilized to prevent COVID
3. receive a greater understanding of how mRNA treatments can be applied to other diseases

Moderator:
Professor Ross McKinnon, Beat Cancer Professorial Chair in the College of Medicine and Public Health, Flinders University Australia

Panellists:
Dr. Rebecka Isaksson, Postdoctoral Research Associate, UCL Department of Chemistry, United Kingdom
PharmD Sunish Shah, Clinical Pharmacy Specialist (infectious diseases), University of Pittsburgh Medical Center,
Interim Clinical Coordinator (antimicrobial stewardship), Lawrence Memorial Hospital
Adjunct Professor, University of St. Joseph College of Pharmacy, US/India
Professor Colin Pouton, Professor of Pharmaceutical Biology, Monash University Australia

This event will showcase the four pillars of the FIP Community Pharmacy Section’s Vision – review, prescribe, dispense, administer. It will also signpost how to empower patients, pharmacists, healthcare professionals about the value of selfcare and the importance of appropriate management for selecting medicines for self-care.

Aim:
Describe appropriate management for selecting medicines for self-care

Learning objectives:

1. List the four pillars of the FIP Community Pharmacy Section’s vision;
2. Define people-centred care;
3. Discuss approaches to empower people, pharmacists and healthcare professionals about the importance of self-care;
4. List minor ailments and common conditions;
5. Identify appropriate management for selection medicines for self-care

Moderator:
Leonila Ocampo, President, Asia Pacific Institute for Medication Management - Philippines

Panelists:
- Daragh Connolly, Vice President Community Pharmacy Section FIP - Ireland
- Lina Bader, FIP Lead for Workforce Transformation and Development FIP - Saudi Arabia
- Charlie Benrimoj, Emeritus Professor, University of Sydney - Australia
- Nardine Nakhla, Faculty Member, University of Waterloo School of Pharmacy - Canada

This webinar will focus on the role of nutrition in the prevention and management of non-communicable diseases, and the role that pharmacists can play to support healthy nutrition choices for different population groups. We plan to invite a range of expert speakers to address important aspects such as the role of community of pharmacists in diabetes prevention, screening, referral and management, the role of dietary supplements in disease management and one example of a community pharmacy nutrition service. In addition, we will also present selected aspects from the FIP handbook on nutrition and weight management for pharmacists, to be launched that day.

Learning objectives:
1: Understand the role of community of pharmacists in diabetes prevention, screening, referral and management
2: Discuss the role of dietary supplements in disease management
3: Share good practices in terms of community pharmacy services focusing on nutrition

Moderator:
Ms Manjiri Gharat, FIP Vice President, India

Speakers:
- Lauren Blum , UNC Eshelman School of Pharmacy, USA
- Iryna Vlasenko, Vice president, International Diabetes Federation, Ukraine
- Joanna Harnett, Senior Lecturer, Sydney Pharmacy School, Australia
- Dr. Josep Tur Marí, Professor of Physiology and Head of the Research Group on Community Nutrition and Oxidative Stress (NUCOX), University of the Balearic Island

This webinar will present selected findings from a recent FIP survey on community pharmacy models and self-care. It will provide an overview of trends affecting community pharmacies’ sustainability, namely the impact of players such as Amazon or the evolution of remuneration models for professional services. It will also provide a snapshot of community pharmacy in China.

Learning objectives:
1: Awareness of different remuneration models and sustainability of pharmacy business.
2: Discuss possible changes in community pharmacies in light of the digital era.
3: Share good practices in terms of evidence-based model regarding remuneration of pharmacy services.

Moderator:
Ema Paulino, FIP Professional Secretary - Portugal

Panellists:
Gonçalo Sousa Pinto and Rúben Viegas, FIP
Lars-Ake Söderlund, President, FIP Community Pharmacy Section
Sónia Queirós, National Association of Pharmacies of PortugalChina
Yue Guan, Deputy chief pharmacist, Head of Clinical Pharmacy Office, Xijing Hospital Affiliated to the Fourth Military Medical University - China

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Moderator:
Patricia Acuna-Johnson, Faculty Member, School of Chemistry and Pharmacy/Faculty of Pharmacy. U. Valparaiso, Chile, U. Valparaiso - Chile
Co-moderator:
Shaun Gleason, Director, Distance Degrees and Programs; Associate Professor, Dept. of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy - USA

Panellists:
- Claire Anderson, Professor of Social Pharmacy, Division of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham - UK
- Arijana Mestrovic, Assistant Professor, Pharma Expert - Croatia
- Pierre Moreau, Dean, Kuwait University - Canada/Kuwait 
- Marilyn Morris, SUNY Distinguished Professor, State University of New York at Buffalo- USA
- Mariam Boakye Gyasi, Kwame Nkrumah University of Science and Technology - Ghana

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the African region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.
Learning objectives:
1) Identify the most prevalent vector-borne diseases in the African region.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.
3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Moderator:
Arinola Joda, Associate Professor, Clinical Pharmacy, Faculty of Pharmacy, University of Lagos - Asst. Secretary/Editor in Chief, APF -Nigeria

Panellists:
- Lilyana Dayo, County Malaria Program Officer and Senior Advisor, Health System Strengthening, County Malaria Program, Kisumu - Kenya
- Azuka Oparah, Professor, Faculty of Pharmacy, University of Benin, Edo State -Nigeria
- James Frimpong, Deputy Programme Manager, National Malaria Control Programme (NMCP) - Ghana
- Folasade Lawal, MD/CEO Victory Drugs Limited, Festac, Lagos- Nigeria
- Gisele Etame, Pharmacist and associate professor; Faculty of medicine and pharmaceutical sciences, University of Douala - Cameroon

This event will set the scene for FIP’s self-care digital events programme. It will describe what the programme consists of and the main learning outcomes. This topic is important because pharmacy teams are increasingly supporting patients with self-care. The event will also describe what self-care involves, its benefits and the future of self-care. There will be a panel discussion about how pharmacy can shape the future of self-care.

Aim:
To describe the future of self-care, its healthcare needs and challenges as well as the role pharmacy plays.


Learning Objectives:
1. Define self-care;
2. List the benefits of self-care;
3. Consider the healthcare needs and challenges of self-care;
4. Discuss the role of pharmacy in shaping the future of self-care.

Chair:
Mr. Lars-Åke Söderlund, President Community Pharmacy Section FIP, Sweden.

Panellists:
Ms. Judy Stenmark, Director General Global Self-care Federation.
Ms. Catherine Laverty, Director of Communications, Global Self-Care Federation.
Mr. Daragh Connolly, Vice President Community Pharmacy Section FIP, Ireland.

To see Part 1, click here. 

The world’s pharmacy team, including students and young pharmacists, is fighting COVID-19. Some students have been working on the frontline during COVID as volunteers. In this webcast, we will talk to pharmacists and students from different regions, learn about their experiences and share their stories.

Learning objectives:
1- Learn about pharmacy students’ and young pharmacists' experiences working in different countries during COVID-19 pandemic.
2- Discuss some of the challenges and possible solutions faced by pharmacy students and young pharmacists working during COVID-19.

Moderator:
Naoko Arakawa, Assistant Professor in International Pharmacy, University of Nottingham -UK
Co-moderator:
Dimitrios-Ilias Balourdas, PhD Candidate, Goethe University Frankfurt, Structural Genomics Consortium - Germany

Panellists:
- Sarah Emerson, Principal Advisor, Immunisation, Ministry of Health - New Zealand
- Gelan Mahmoud Zakhera, Registered Pharmacist at a Hospital Pharmacy International Pharmaceutical Student’s Federation - Egypt

Guests:
- Kats, Hospital pharmacist in training Haaglanden Medisch Centrum - The Netherlands

- Comfort Tanaka Gutu, Public Health Pharmacist (District Pharmacist), Ministry of Health and Childcare - Zimbabwe

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Moderator:
Jacqueline Surugue, Hospital Pharmacist, France

Panellists:
- Aukje Mantel-Teeuwisse, Director Utrecht University School of Pharmacy - The Netherlands
- Paul Fahey, Independent Healthcare Consultant - Ireland
- Charlotte Verner Rossing, Director of Research and Development Pharmakon - Denmark

Biopharmaceutical drug product development is a multistage process that involves various activities from molecule design to process engineering and validation. QbD based approaches can help connect consecutive stages of product development to each other and ultimately to the desired clinical performance. The webinar will address practical approaches to utilizing QbD based approaches for biologics drug product formulation and process development as well as manufacturing using case studies as examples.

Learning objectives:
*How QbD is applied to discrete stages in biologics development and manufacturing
*Application of QbD that is phase- appropriate
*Case studies of real- life examples

Moderator:
Mathew Cherian, Consultant - USA
Co-moderator:
Maria Mantziri, Quality Project Manager, IPS ExCo Associate - Germany

Panellist:
Krishnan Sampath, Executive Director, Analytical and Drug Product Sciences MacroGenics - USA

COVID-19 has not only changed our daily routines, it also changed the traditional education system into distance learning or hybrid model. And convening classes with live and pre-recorded lessons challenged the pharmacy academics to innovate methods to engage their students in active online learning. This webinar will focus on pharmacy schools and accreditation bodies’ roles to make online learning creative and effective for students. Immersing pharmacy students in research, and meeting pharmacy students’ needs in an online environment will be addressed by the experts in their fields. Also, pharmacy students will discover enrichened ways to adjust and foster their education in online/virtual delivery.
Learning objectives:
1. To explore the roles of accreditation bodies in the quality of pharmacy programmes and transition to online
2. To determine the roles of schools of pharmacy in maintaining quality of programmes including skills development and experiential learning (especially when transitioning to online/virtual learning)
3. To describe the skills that professors/teachers must adopt/adapt to maintain quality of programmes (especially online/virtual versions)
4. To discuss how learners should adapt their learning to maintain their quality of learning during online/virtual delivery

Moderator:
- Carlo Marra, Dean School of Pharmacy University of Otago - New Zealand
Facilitator:
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham- UK
Panellists:
- Vibhu Solanki, Associate Professor of Community Pharmacy and Digital Education University of Nottingham - UK
- Janet P. Engle, Executive Director Accreditation Council for Pharmacy Education- USA
- Ilkay Erdogan Orhan, Dean Gazi University, Faculty of Pharmacy - Turkey
- Yahya Choonara, Professor University of Witwatersrand - South Africa

The 3rd episode of the programme explores FIP Development Goal 16: Communicable diseases. Through this goal, we aim to oversee the prevention, surveillance, scientifically strategic management and therapeutic optimisation of communicable and vector-borne diseases. This event will take place during World Immunisation Week and it will reiterate the commitment of pharmacists, pharmaceutical scientists and pharmaceutical educators to improving vaccination coverage around the world, and to further support the prevention and management of communicable diseases.

Event outcomes:
1. Describe and explain the components of FIP DG 16 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 16 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 16
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation - Spain

Facilitator:
Rúben Viegas, FIP Practice Development Projects Coordinator - Spain

Panellists:
- Ian Bates, Chair of pharmacy education, UCL, FIP Director of the Workforce Development Hub - UK
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden
- Eduardo Savio, President Pharmaceutical Forum of the Americas - Uruguay
- Cameron Phillips, Academic and Senior Pharmacist, Flinders University College of Medicine and Public health & Flinders - Australia

Los farmacéuticos tienen una posición privilegiada para ayudar a las comunidades y a los pacientes a protegerse de las enfermedades transmitidas por vectores (ETV). En este webinar se describirán las ETV con mayor prevalencia en las Américas; posteriormente se identificaran las intervenciones farmacéuticas más relevantes en este ámbito y por último se presentarán tres experiencias desarrolladas por el Foro Farmacéutico de las Américas referentes al abordaje farmacéutico de las ETV.

Objetivos de aprendizaje:
1) Reconocer los principales conceptos relacionados con las enfermedades transmisibles por vectores.
2) Describir las características y la morbi-mortalidad de las principales enfermedades transmisibles por vectores en la región de las Américas.
3) Determinar las actividades que el farmacéutico puede desarrollar desde la farmacia para la prevención, detección, control y gestión de la farmacoterapia de las enfermedades transmisibles por vectores.
4) Identificar las experiencias desarrolladas por el Foro Farmacéutico de las Américas para apoyar las acciones de los farmacéuticos en la lucha contra las enfermedades transmisibles por arbovirus.

Moderator:
Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica Farmacéutica
Federación Internacional Farmacéutica (FIP) - Portugal
Facilitator:
Yajaira Quesada Rojas, Secretaria Técnica - Foro Farmacéutico de las Américas - Costa Rica.

Ponentes:
-Cristina Fernández Barrantes, Farmacéutica, Centro de Información de Medicamentos del Servicio de Farmacia del Hospital San Juan de Dios, San José-Costa Rica
-Nuria Montero Chinchilla, Farmacéutica, Directora de Práctica Farmacéutica
Foro Farma-Costa Rica.
-Sofía Segura Cano, Farmacéutica, Programa Institucional para la Persona Adulta y Adulta Mayor de la Universitad Costa Rica

This session targets stakeholders involved in professional and continuing pharmacy education. Its purpose is to equip educators with strategies and techniques used in cultural sensitivity training for pharmacy students, an essential component of modern pharmacy education and optimal patient care. Specifically, experts will share strategies and lessons learned from creating and tailoring educational activities within the pharmacy curriculum that address cultural sensitivity.

Learning Objectives
At the end of this session, participants will be able to:
• Identify key steps in creating activities aimed to improve cultural sensitivity among pharmacy students
• Describe strategies educators can use to engage students in learning about and addressing the needs of patients from different culture
• Consider strategies for integrating cultural sensitivity training in pharmacy curricula

Moderator:
- Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain

Panellists:
- Mohamed Amin, Associate Professor, Beirut Arab University - Lebanon
- Cherie Lucas, Senior Lecturer and Clinical Education Manager (Experiential Placements), University of Technology - Australia
- Gizem Gülpınar, Research Assistant, Ankara University - Turkey

As the second installment of the two-part series on pharmacists’ role in ensuring patient safety, this webinar will explore medicines reconciliation as an essential service in ensuring patient safety. As transitions of care bear an increased risk of medication discrepancies, which lead to adverse effects, pharmacist-led medicines reconciliation has been demonstrated to effectively resolve such discrepancies and contribute to avoiding patient harm. Pharmacy experts and FIP team members from around the world will be presenting data supporting this service in addition to the FIP toolkit on medicines reconciliation launched this February.
Learning objectives:
• Define medicines reconciliation and review data supporting the clinical and economic benefits associated with the service
• Explore examples of medicines reconciliation practices from different regions
• Become familiar with the FIP medicines reconciliation toolkit to support the advocacy and implementation of the service

Moderator:
Nam-Anh Nguyen, Medication Safety Advanced Practice Pharmacist Sir Charles Gairdner Hospital (Perth, Australia) & The Society of Hospital Pharmacists of Australia - Australia

Panellists:
- Jonathan Penm, Senior Lecturer The University of Sydney School of Pharmacy
Assistant Secretary, Hospital Pharmacy Section - Australia
- Régis Vaillancourt, Director of Pharmacy
Children’s Hospital of Eastern Ontario - Canada
- Veerle Foulon, Professor KU Leuven - Belgium
- Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre - Canada

Pharmacy technicians have a critical role in the delivery of healthcare and patient care services. This webinar will offer an overview of current research and publications about pharmacy technicians’ contributions. Speakers will also discuss the importance of data, evidence, and research related to pharmacy technician practice and describe current literature that demonstrates the value of the pharmacy support workforce.

Learning objectives:
· Understand the importance of data, evidence, and research related to the role and practice of pharmacy technicians
· Learn about the many contributions of pharmacy technicians on an international level
· Describe recent and upcoming publications regarding pharmacy technicians

Moderator:
- Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board PTAC - United States
Co-moderator:
Teri-Lynne, Fogarty Lecturer/ Coordinator of Pharmacy technician programme Nelson Mandela University PTAC member - South Africa

Panellists:
- Kimberly McKeirnan, Associate Professor, Pharmacotherapy Director for the Center for Pharmacy Practice Research Washington State University, PTAC Member - United States
- Charlotte Verner Rossing, Director of R&D
Pharmakon, Danish College of Pharmacy Practice, Vice-chair FIP Special Interest Group on Pharmacy Practice Research - Denmark
- Tamara Köhler, Consultant and lecturer, PhD Candidate FPZ-instituut -Netherlands
- Michael Mungoma, Dean, School of Pharmacy Mount Kenya University PTAC Member - Kenya

This webinar will explore pharmacists’ frontline role in reducing medication-related harm through medicines use review (MUR). Pharmacists from different care settings from across the world will discuss how MUR has been integrated into their clinical practice in addition to the evidence for the clinical and economic benefits supporting this service. Finally, the FIP toolkit on MUR, launched in December 2020, will be presented.
• Define Medicines Use Review (MUR) and discuss the clinical and economic evidence supporting its implementation
• Explore examples of MUR practices from different regions
• Become familiar with the FIP MUR toolkit to support the advocacy and establishment of the service

Moderator:
- Marja Airaksinen, Chair of the FIP Working Group on Patient Safety - Finland

Panellists:
- Filipa Alves da Costa, Assistant Professor University of Lisbon - Portugal
- Nai-Hwa Mei, Clinical Pharmacist Specialist
Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital - China Taiwan
- Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre Practice Development Projects Assistant (consultancy) - Canada

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The Programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 2nd episode of the FIP “Setting goals for the decade ahead” programme explores FIP Development Goal 18: Access to medicines, devices and services. Through this goal, we aim to optimise access to effective and innovative medicines, medical devices and pharmaceutical care through frameworks, education and training. Together we will showcase the importance of access to medicines, devices and services as a means to attaining better health for all.

Event outcomes:
1. Describe the FIP Development Goals and explain the components of DG 18 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 18 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 18
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Marwan Akel, FIP Projects Manager – Workforce FIP, Lebanon
Co-moderator:
Desak Ernawati, FIP Global Lead for DG4 Advanced practice & specialisation, Indonesia

Panellists:
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services, Germany
- Ema Paulino, FIP Professional Secretary- Portugal
- Giovanni Pauletti, Associate Dean & Pfeiffer Chair University of Health Sciences and Pharmacy in St. Louis -USA

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals.

Online delivery of goods became very common nowadays, and even increased during COVID-19 pandemic and related lockdowns. The way consumers obtain medicines, as special type of goods, is also changing. In some countries, buying medicines online is becoming common practice, because buyers are preferring to order their medicines through a click of a button rather than taking a trip to a pharmacy or a drug store. However, online customers may have difficulty knowing whether an Internet pharmacy is a legitimate operation, without the same confidence as they would have had in the neighborhood pharmacy. What are the practices in place to make sure that the online patient or customer can rely that they will receive the medicine they need? What are the advantages and disadvantages to accessing medicines on-line from patients, as well as from pharmacists’ point of view? Since medicines are regulated products and the need for consideration of ethical issues in access to medicines is important, the online pharmacy services have both advantages and disadvantages. What are the medicines patients are allowed to receive online in different countries? What is the scope of online pharmaceutical services vis-à-vis medicine procurement, distribution, online prescriptions, internet drug information, pharmaceutical care services, etc.?

Chair:
- Sari Westermarck, Owner-Proprietary pharmacist, Vihti 1. Pharmacy - Finland

Panellists:
- Manjiri Gharat, FIP Vice-President, FIP - India
- Filipa Alves da Costa, Assistant Professor, University of Lisbon - Portugal
- John Hertig, Board President Alliance for Safe Online Pharmacies - USA

For a young and early career pharmacist or pharmaceutical scientist, choosing the right career is no easy feat. Not only are the options too numerous for one to choose sometimes, they can also seem quite few, depending on one’s exposure. Notwithstanding, the path to each career requires intricate and timely preparation to gain the required expertise.

This FIP YPG webinar seeks to introduce young pharmacists and pharmaceutical scientists to the Career development cycle and how it can effectively be used as a tool for professional development. Each speaker will cover fundamental insights with practical examples from their personal and professional experience with an aim to equip attendees with personalized and strategic leads for their effective career evolution.

The learning outcomes include:
1. Attendees will gain insights about the steps in the career development cycle.
2. Attendees will understand how to effectively utilize the continuing professional development cycle (Reflection, Planning, Action and Evaluation).
3. Attendees will learn about effective reflection and subsequent planning as a tool for continuing professional development
4. Attendees will gain knowledge on how properly carry out the evaluation process after taking appropriate action as it relates to career development.

Chair:
- Ikwaibom Umoiyoho, Hospital Pharmacist, Zenith Medical and Kidney Centre - Nigeria

Moderator:
- Ravi Sharma, Director of England, Royal Pharmaceutical Society - United Kingdom

Panellists:
- Anisha Sandhu, Lecturer, Monash University - Malaysia
- Arit Udoh, Global Lead FIP DG4/ Senior Clinical Project Manager, University of Birmingham - United Kingdom
- Toyin Tofade, Dean and Professor, Howard University College of Pharmacy - United States of America

Topics to address:
• Technology, which was first developed to facilitate communication, has now grown into a global network of computer systems that link multiple platforms and create interrelationships between governments, academic institutions, businesses and consumers.
• Implementing healthcare based on information system and technologies (e.g. e-health) had been proposed as a way to improve health services. Hence, the scope of pharmacy practice has expanded to the provision of pharmaceutical services via the internet.
• This session will outline some of the questions around the strengths and weaknesses of the online pharmacies, their threats, but also opportunities for e-pharmacy in the future.
• Some of the largest global e-commerce companies have shown that they have a robust supply chain to really disrupt the existing pharmaceutical supply chain. Pharmacists have responded with concern to these giants’ move into the pharmacy and e-pharmacy market. How can pharmacists take advantage of modern online marketplaces? Does face-to-face interaction with the patient still make a difference? What is the added value of online pharmaceutical care services compared to other e-commerce places?

Chair:
- Manjiri Gharat, Vice-President, FIP - India

Panellists:
- Jaime Acosta, Community Pharmacy Section’s Executive Committee Member, FIP CPS - Spain
- Ardalan Mirzaei, x, The University of Sydney - Australia
- Ukamaka Okafor, Director, Education and Training; Coordinator of Supply Chain and Logistics Project Management Unit, Pharmacists Council Nigeria - Nigeria

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The Programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 1^st episode of the Programme focuses on a goal that impacts us all. FIP Development Goal 10 Equity & Equality calls for clear strategies to address inequalities in the pharmaceutical workforce, widen access and equity of pharmaceutical care services & access, as well equity in global capacity in pharmaceutical sciences development. In addition to meeting the event outcomes outlined below, this series opener will also feature special launches from FIP:

- A new digital FIP-EquityRx Collection “Inequities unmasked”

- An exclusive release of a global statement on vaccine equity

- A first look at a new resourceful online site for FIP-EquityRx, FIP’s programme on Equity & Equality in pharmacy

Event outcomes:

1. Describe the FIP Development Goals and explain the components of DG 10 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 10 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 10
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

FIP’s Regulators’ Forum will present a new regulatory vaccination preparedness self-assessment tool and risk assessment. Foundational regulatory needs will be presented to ensure oversight, quality assurance and public protection as the scope of pharmacist’s patient care is expanded to include prescribing, vaccination and testing in order to address population health needs during a pandemic. A brief overview of the data collected by FIP on the role of pharmacists in vaccinations and other FIP documents will also be presented.

Learning Objectives:
- Awareness of the global variation of the pharmacist scope of practice reported FIP global survey
- The valuable and available resource of information contained in the FIP documents regarding pharmacist vaccination and expanded scope of practice.
- Foundational regulatory needs for public protection when expanding the pharmacists’ scope of practice.
- Availability of a vaccination preparedness self-assessment tool.

Moderators:
- Ronald Guse, Chair, FIP Regulators Forum - Canada
- Catherine Duggan, CEO, FIP - The Netherlands

Panellists:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, FIP - The Netherlands
- Lemrey “Al” Carter, Executive Director, National Association of Boards of Pharmacy - USA

Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. As a role that involves direct contact with the patient and the administration of a product by injection, it may still generate some concerns among pharmacists with regards to the administration procedure, common errors and the management of anaphylactic reactions. This webinar will describe such procedures and address common questions and concerns.

After this webinar the participants should have a better understanding of the following topics:

- Vaccine administration routes and procedures.
- Common errors that may be committed during vaccine administration and how to avoid them.
- Prevention and management of adverse reactions, including anaphylactic shock.

Moderator:

- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon

Panellists:

- Lisa Nissen, Professor and Head of the School of Clinical Sciences, Queensland University of Technology - Australia
- Maria Mendes, Area Manager at the Centre for Medicines Information & Health Interventions (CEDIME) at the National Association of Pharmacies - Portugal

This global virtual Summit – the programme finale – is a high-level event in which we will recap the primary outcomes of the 24-event digital series. Together, we will adopt the FIP Commitment to Action on Vaccination in Pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

This roundtable event follows 6 regional events – episodes 3.1 to 3.6 of the programme – which dissected priorties, needs and barriers across the world’s six regions. We now bring back the key outcomes from the six regional discussions int one roundtable to identify common priorities for action to transform vaccination. Each regional perspective will be represented by the panelists, alongside other leaders and stakeholders.

Objective
To understand the commonalities of different jurisdictions in delivering on the Transformation of Vaccination Globally and Regionally

Moderator:
- Ronald Guse, Chair, FIP Regulators' Forum, National Association of Boards of Pharmacy, Canadian Consultant - Canada

Co-moderator:
- Lina Bader, Lead for Workforce Transformation & Development, Programme Lead – Transforming Vaccination Globally & Regionally, International Pharmaceutical Federation (FIP) - Saudi Arabia

Speakers:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists - Belgium
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Nadia Al Mazrouei, President, EMROPharm Forum, Academic &Healthcare consultant - UAE
- Prosper Hiag, President, African Pharmaceutical Forum - Cameroon
- John Jackson, President, Western Pacific Pharmaceutical Forum - Australia
- Eduardo Savio, President, Pharmaceutical Forum of the Americas - Uruguay

The Global COVID-19 impact on, consumer behavior/patient expectations, healthcare, and pharmacy workforce was noticeable.
The importance of pharmacy technicians in healthcare delivery pre-COVID-19, during crisis, and post-COVID-19 is crucial for the healthcare and patient services.
Pharmacy technicians from different work settings, community, hospital and pharmacy technicians’ association share their experiences with the public

Moderators:
Vijay Sarma, VP Pharmacy Marketing, McCann Health, Canada
Teri-Lynne Fogarty, Lecturer/ Coordinator of Pharmacy technician programme, Nelson Mandela University, South Africa

Speakers:
Isnarti Abu Aman, Pharmacy Technician Executive, Khoo Teck Puat Hospital, Singapore

Lorah Hickman, Senior Pharmacy Technician for Workforce and Development
Alfred Hospital, Australia

Birgitte Jeanette Andersen, Pharmaceutical consultant, Denmark

Mike Johnston, CEO, National Pharmacy Technician Association, USA

Event 3.6 focuses on the regional needs and drivers for transforming vaccination in the Americas region. This involves discussing the progress made in countries in the Americas with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation.

Moderator:
- Nuria Montero Chinchilla, Directora de Práctica Farmacéutica, Foro Farmacéutico de las Américas - Costa Rica
- Carlos Lacava, Vice-presidente, Federación Internacional Farmacéutica (FIP) - Uruguay

Facilitator:
- Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica, Federación Internacional Farmacéutica (FIP) - España

Speakers:
- Ligia Álvarez, Presidente, Colegio Nacional de Farmacéuticos - Panamá
- Maria Isabel Reinoso, Presidente, Confederacion Farmaceutica Argentina - Argentina
- Luis Baez, Presidente, Asociación de Químicos Farmacéuticos del Paraguay-AQUIMFARP - Paraguay
- Marco Oswaldo Padilla Puruncajas, Presidente, Colegio de Químicos, Bioquímicos y Farmacéuticos de Pichincha, Ecuador
- Mariela Méndez Ferreira, Presidente, Asociación de Química y Farmacia del Uruguay- Uruguay

In the fifth of six regions we dissect, event 3.5 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves discussing the progress made in Africa with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from Africa join us for a true regional perspective.

Objective
To understand the African perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
Prosper Hiag, President, African Pharmaceutical Forum (APF), Member of the Council of the FIP – Cameroon
Jacqueline Surugue, Vice President – International Pharmaceutical Federation (FIP)- Past President of the Hospital Section Chair of the FIP Pharmaceutical Technology Forum, Hospital Pharmacist, Centre Hospitalier Georges Renon – France

Facilitator:
Nilhan Uzman, Lead for Education Policy and Implementation, International Pharmaceutical Federation (FIP) – Turkey

Speakers:
Yvonne Yirenkyiwaa Esseku, Vice President, Pharmaceutical Society of Ghana – Ghana
Redouane Soualmi, General Secretary, Algerian Pharmaceutical Federation – Fédération Algérienne de Pharmacie – Algeria
Nahil Dave, Superintendent Pharmacist, Pharmaceutical Society of Kenya – Kenya

In the fourth of six regions we dissect, event 3.4 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific. This involves discussing the progress made in Western Pacific countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the Western Pacific join us for a true regional perspective.

Objective
To understand the Western Pacific perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
John Jackson, President, Western Pacific Pharmaceutical Forum – Australia
Parisa Aslani, Vice-President, International Pharmaceutical Federation (FIP) – Australia

Facilitator:
Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation (FIP)

Speakers:
Gilda Sebua-Saljay, President, Philippine Pharmacists Association – Philippine
Peter Guthrey, Senior Pharmacist- Strategic Policy, Pharmaceutical Society of Australia – Australia
Scarlett Pong, President, The Pharmaceutical Society of Hong Kong (PSHK) – Hong Kong

The world’s pharmacy team is fighting COVID-19 in a variety of ways. This webinar will host stakeholders working in various pharmacy sectors and from different geographical regions to share examples and draw on what we can learn in our pursuit of resilience. Research-driven findings will be shared that may aid in developing and advancing resilience within ourselves, for our patients, colleagues and the systems we are a part in our ability to tackle very challenging times. This event is delivered by FIP in collaboration with GRiT – Global Resilience Team, Led by: Dr Karen Whitfield.

The webinar aims to:
- Introduce participants to GRiT - Global Resilience Team ethos; a collaborative team passionate for raising awareness of the importance of developing resilience in our workforce.
- Showcase global perspectives from research and practice related to resilience in pharmacy.
- Share experiences in developing relevant and practical material to build into pharmacy curricula.

Moderator:
- Prof. Zubin Austin, Koffler Research Chair in Management, Leslie Dan Faculty of Pharmacy and Institute for Health Policy, Management, and Evaluation - Faculty of Medicine at the University of Toronto - Canada

Event Chair:
- Dr Catriona Bradley, Executive Director, The Irish Institute of Pharmacy - Ireland

Panellists:
- Dr Karen Whitfield, Associate Professor, School of Pharmacy, The University of Queensland - Australia
- Dr Sarah Wills, Senior Lecturer, The University of Manchester - UK
- Dr Dalia Bajis, Assistant Professor, Mohammed Al-Mana College for Medical Sciences - Saudi Arabia
- Dr Kyle Wilby, Associate Dean (Undergraduate) and Associate Professor, School of Pharmacy, University of Otago - New Zealand
- Dr Vibhuti Arya, Global Lead, Equity and Equality, International Pharmaceutical Federation (FIP) - USA
- Elizabeth Shekalaghe, Registrar /CEO, Pharmacy Council Tanzania - Tanzania
- Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - The Netherlands

In the third of six regions we dissect, event 3.3 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region (EMR). This involves discussing the progress made in EMR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the EMR join us for a true regional perspective.

Objective:
To understand the Eastern Mediterranean perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Nadia Al Mazrouei, President, EMROPharm Forum - UAE
- Samira Shammas, Vice President, International Pharmaceutical Federation (FIP) - Jordan

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Ziad Nassour, President, Lebanese Order of Pharmacists - Lebanon
- Adi Al-Nuseirat, Technical Officer, WHO Eastern Mediterranean Regional Office - Egypt
- Zeid Kilani, President, Jordanian Pharmacists Association - Jordan
- Alaa Hayallah, President, Pharmacists Syndicate in Assiut - Egypt
- Faraz Ashraf, Deputy director pharmacy / Joint Secretary of Pakistan Pharmacists Association, The children's hospital and the institute of child health, Lahore - Pakistan
- Mohammed Al-Nuzili, Governing Board President, Yemen Community Pharmacy Syndicate - Yemen

In the second of six regions we dissect, event 3.2 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region (SEAR). This involves discussing the progress made in SEAR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the SEAR join us for a true regional perspective.

Objective:
To understand the South East Asian perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Ashok Soni, Vice President, International Pharmaceutical Federation (FIP) - UK

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Rao Vadlamudi, Immediate Past President, Indian Pharmaceutical Association (IPA) - India
- Lalith Senarathna, Senior Lecturer, Rajarata University of Sri Lanka - Sri Lanka
- Manisha Shridhar, Regional Advisor, WHO Regional Office for South-East Asia - India
- Kampanart Huanbutta, Assistant Dean, Faculty of Pharmacy, Burapha University - Thailand

In the first of six regions we dissect, event 3.1 focuses on the regional needs and drivers for transforming vaccination in Europe. This involves discussing the progress made in European countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Objective:
To understand the European perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists (EAHP) - Belgium
- Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Alain Delgutte, President-elect, Pharmaceutical Group of the European Union (PGEU) - Belgium
- Monika Derecque-Pois, Director General, European Healthcare Distribution Association (GIRP) - Belgium
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists - Malta
- Niyazi Cakmak, Technical Officer, WHO Regional Office for Europe - Denmark
- Lieven Lieven Zwaenepoel, Past President, Belgian Pharmaceutical Association (APB) Belgium
- Mesut Sancar, Representative, Turkish Pharmacists' Association (TPA) - Turkey

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Learning Objectives:
After this webinar the participants should have a better understanding of the following topics:
1. Vaccine quality and safety assurance.
2. Vaccine hesitancy and how to address it through transparent and evidence-based arguments, and positive examples of the value of vaccines.
3. The role of pharmacists in building vaccine confidence.

Programme: Communicating vaccine safety, building vaccine confidence
Moderator:
- Giovanni Pauletti, FIP’s Scientific Secretary
Chair, Department of Pharmaceutical & Administrative Sciences, St. Louis College of Pharmacy - USA

Speakers:
- Alberta Di Pasquale, Director, Global Medical Affairs Vaccine Science and Medical Education Lead, GSK - Belgium
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists – Spain

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To summarise and discuss the impact of FIP Development Goals in the Transformation of Vaccination Globally and Regionally.

Moderators:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation - The Netherlands
- Carlene Ngoma, Global Lead for Equity and FIP Program co-ordinator for FIP transformation of Vaccination Globally and Regionally, International Pharmaceutical Federation - Australia

Speakers:
- Arit Udoh, Senior Clinical Project Manager, University of Birmingham - UK
- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon
- Chima Amadi, Education and Training Personnel, Pharmacists’ Council Nigeria - Nigeria
- Catherine Duggan, Chief Executive Officer, International Pharmaceutical Federation - The Netherlands
- Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal - South Africa
- Lars-Åke Söderlund, President the Community Pharmacy Section, International Pharmaceutical Federation - Sweden

Aim
To describe an evidence-based approach to self-care of mild COVID-19 symptoms

Learning Objectives:
• Describe approaches for preventing the spread of COVID-19
• List symptoms of COVID-19 – similarities and differences to influenza;
• Identify myths associated with self-care of COVID-19.
• Describe how mild symptoms such as fever and pain should be managed;
• Discuss when to refer more serious cases (escalating care in COVID-19).

Target audience – all those involved in the primary health care response to the coronavirus pandemic

Programme:
1. Welcome – Moderator Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation

2. COVID-19: preventing its spread and understanding its symptoms – Jaime Acosta-Gómez, Community Pharmacist and Pharmacy Owner, Spain

3. Dispelling myths about self-care treatments of COVID-19 – Christopher John, FIP Lead for Data and Intelligence

4. How to manage mild symptoms – self-care case study. Lars-Åke Söderlund, President FIP Community Pharmacy Section

5. Panel Discussion – questions and answers – All speakers

The COVID-19 pandemic has created an urgent need for diagnostic testing of patients and populations. In response, a multitude of COVID-19 tests are available to use from many different manufacturers and organisations. FIP has created a counselling information guide to assist practising pharmacists around the world in talking to patients who have questions concerning COVID-19 tests. This joint FIP-ASHP online event will present the newly developed guidance on Evaluation of Diagnostic Testing & Methods, as well as tools for pharmacists developed by the American Society of Health-System Pharmacists (ASHP). Panellists will discuss issues about care and how to manage the risks with evidence is the focus.

Moderator:
Zuzana Kusynova, Lead for Policy, Practice and Compliance, FIP, Netherlands

Panellist:
Mary Ann Kliethermes, Director, Medication Safety and Quality, American Society of Health-System Pharmacists (ASHP), USA

Catherine Duggan, CEO, FIP, Netherlands

Julien Fonsart, Senior specialist in laboratory medicine pharmacist, Hôpital Lariboisière, Université de Paris, France

Ally Dering-Anderson, Clinical Associate Professor in the Department of Pharmacy Practice & Science, University of Nebraska College of Pharmacy, USA

Margaret Underwood, Pharmacy student & FIP Intern, FIP, USA

Jasminka N Sarunac, Lead Pharmacist Investigational drugs/Clinical trial, Pharmacoepidemiologist, John Hunter Hospital, Australia

In this episode – “Pharmacist Vaccinators and Patient Safety” – is an interview format that focuses on the FIP Development Goal 19: Patient Safety from the perspective of vaccination by a pharmacist. The role of pharmacists in delivering safe vaccinations; participation in vaccination monitoring and adverse event reporting, and the role of improving vaccination rates as a method of reducing overall harm caused by preventable disease.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 19: Patient Safety in the Transformation of Vaccination Globally and Regionally

Moderator:
Lars-Åke Söderlund, Executive Advisor, Apoteket AB - Sweden

Speakers:
Ramesh Walpola, Lecturer, School of Population Health, UNSW Sydney - Australia
John Hertig, Associate Professor, Butler University - USA
Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal
Alpana Mair, Head of Prescribing and Therapeutics for Scottish Government, coordinating delivery of Governments work programme and advising Ministers on Quality, safety and effectiveness of Prescribing, Scottish Government - UK

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 18: Access to Medicines and Services in the Transformation of Vaccination Globally and Regionally

Moderator:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Panellists:
Jane Barratt, Secretary General, International Federation on Ageing - Canada
Alexandra Ruth, Doctoral Student, Johns Hopkins Bloomberg School of Public Health - USA

Se generó, durante esta pandemia, diversos tipos de evidencia respecto a los tratamientos para la Covid-19 pero aún así, el farmacéutico se enfrenta a la necesidad de tomar decisiones en ausencia de evidencia científica. Para apoyar la toma de decisiones, se compartirán los caminos emprendidos en el Hospital G. Marañón para la selección y protocolización del tratamiento para Covid-19 mostrando las herramientas utilizadas. La segunda parte será dedicada a los sistemas de farmacovigilancia (FV) sostenibles. La FV no es una actividad de lujo sino que es la base del uso seguro de medicamentos. Involucrar al paciente. Uso off-label de medicamentos.

1. Identificar los principales retos en la selección y protocolización de los tratamientos para Covid-19 en un contexto de falta de evidencia científica.
2. Analizar rol de las agencias reguladoras, la Comisión de Farmacia y Terapéutica del hospital, el grupo de expertos Covid-19 y grupo PROA del hospital y el farmacéutico en enfermedades infecciosas.
3. Compartir la experiencia en el abordaje de la selección y protocolización del tratamiento para Covid-19.
4. Discutir estrategias para organizar sistemas sostenibles para la gestión de riesgos de productos farmacéuticos y dispositivos médicos en la farmacia hospitalaria post-Covid.

Moderadora:
Nora Gerpe, Química Farmacéutica Asociación de Química y Farmacia del Uruguay-Uruguay

Panelistas:
Carmen Rodriguez, Farmacéutica Hospitalaria Hospital General Universitario Gregorio Marañón - España
Lucila Castro Pastrana, Full Professor Universidad de las Américas, Puebla - México

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 17: Antimicrobial Stewardship in the Transformation of Vaccination Globally and Regionally

Moderator:
Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health Chair: Global Respiratory Infection Partnership, University of KwaZulu-Natal - South Africa

Speakers:
Alfonso Pereira Céspedes, Pharmacist, University of Costa Rica - Costa Rica
Manjiri Gharat, Vice President, Indian Pharmaceutical Association - India
Philip Howard, Consultant Pharmacist, Leeds Teaching Hospitals NHS Trust - UK
Debra Goff, The Ohio State University Medical Center - USA

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Outcomes
To understand the impact of FIP Development Goal 13: Policy Development in the Transformation of Vaccination Globally and Regionally

Moderators:
Ellen Schafheutle, Professor of Pharmacy Policy and Practice Centre for Pharmacy Workforce Studies, The University of Manchester - United Kingdom
Chima Amadi, Education and Training Personnel Pharmacists’ Council Nigeria - Nigeria

Panellists:
1. Walter da Silva João, President Brazilian Federal Council of Pharmacy - Brazil
2. Howard Rice, Hon. President & International Liaison Officer Pharmaceutical Association of Israel - Israel
3. Shane Jackson, Community and Consultant Pharmacist - Pharmaceutical Society of Australia - Australia

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Objective
Identifying mechanisms for transforming vaccination using FIP DG7: Advancing integrated services

Moderator:
Marwan Akel, Chairperson Pharmacy Practice Department Lebanese International University - Lebanon

Panellists:
1.Barbel Holbein, Lecturer and Researcher University of Bremen; University of applied sciences-Baden Württemberg - Germany
2.Sofía Segura, Professor University of Costa Rica and College of Pharmacists of Costa Rica - Costa Rica
3. Pamela Logan, Director of Pharmacy Services Irish Pharmacy Union - Ireland
4. Scarlett Pong, President of The Pharmaceutical Society of Hong Kong - Hong Kong

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Power Point slides

Moderators:
Arit Udoh, Clinical Project Manager University of Birmingham-United Kingdom
Desak Ketut Ernawati, Academic and Researcher Faculty of Medicine Universitas Udayana-Indonesia

Speakers:
1. Hanne Merete Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association - Norway
2. Andi Shirtcliffe, Clinical Chief Advisor – Pharmacy, Quality Use of Medicines, Allied Health Ministry of Health - New Zealand
3. Greg Eberhart, Registrar Alberta College of Pharmacy-Canada
4. Jorge Batista, International Affairs Lead Portuguese Pharmaceutical Society - Portugal

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d'affections sous-jacentes, les femmes enceintes et d'autres.
La menace d'une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Ce panel discutera comment plusieurs pays francophones relèvent ce défi grâce à la vaccination en pharmacie, et comment les pharmaciens peuvent contribuer à améliorer la couverture vaccinale contre la grippe et contre d’autres maladies évitables par la vaccination tout au long de la vie. Le panel discutera également du rôle du pharmacien d’officine dans la réponse aux doutes et aux mythes sur les vaccins. Il abordera également la question de la nécessaire collaboration interprofessionnelle et de sa valeur ajoutée pour les patients et pour la société, la vaccination en pharmacie représentant une extension et non un déplacement de l’accès à la vaccination.

Après ce webinaire, les participants devraient comprendre :
1. L'impact de la vaccination en pharmacie sur les taux de couverture vaccinale ;
2. Pourquoi les populations vulnérables (personnes âgées, patients chroniques et professionnels de la santé) devraient être vaccinées contre la grippe, en particulier dans le contexte de la pandémie;
3. Le rôle des pharmaciens dans l’amélioration de la couverture vaccinale tout au long de la vie contre différentes maladies;
4. Les stratégies adoptées par certains pays francophones pour augmenter la couverture vaccinale contre la grippe via les pharmacies et comment ils ont surmonté l'opposition liée aux corporations par des preuves et des approches collaboratives.

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Moderators:
Dominique Jordan, FIP President - Switzerland
Catherine Duggan, FIP CEO - the Netherlands

Panellists:
1. Ema Paulino, FIP Professional Secretary - Portugal
2. Paul Sinclair, Community Pharmacist Chair Board of Pharmaceutical Practice - Australia
3. Giovanni Pauletti, FIP Scientific Secretary - USA
4. Ross MacKinnon, Chair of FIP Board of Pharmaceutical Science, FIP - Australia
5. Ralph Altiere, Chair of FIP Education FIP - USA
6. Ian Bates, Chair of pharmacy education, UCL - UK
7. Allie Jo, Director, State Policy National Alliance of State Pharmacy Associations -
USA

Presentation slides are available here.

FIP is launching a transforming vaccination globally and regionally 24 part series. In series 1, we are running 8 episodes that focus on identifying the needs for vaccine transformation across science, practice and workforce and education. In today’s event, part 6, we will be focusing on practice needs and our guest panel will discuss how the workforce and education can help transform vaccination globally and regionally discussing initial education, continuing education and the potential for progress in these areas.

Scope: Workforce & education needs: Focus on initial education

What is education currently like in your country with regards to vaccination for both initial education and continuing education?

How can this be improved?

Has education kept up with the advances in pharmacy services development?

Moderators:
Ralph Altiere, Dean University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA
Ian Bates, Chair of pharmacy education UCL - UK

Panellists:

1. Lisa Nissen, Head, School of Clinical Sciences Queensland University of Technology -Australia
2. João Guedes, President, IPSF, International Pharmaceutical Students' Federation - Portugal
3. Romeo C. Ongpoy, Jr., Dean School of Pharmacy at Romeo Ongpoy - Philippines

Tras la irrupción de la infección respiratoria por el nuevo coronavirus SARS-CoV-2, el desarrollo de vacunas capaces de proporcionar protección individual y poblacional frente a este virus se presenta como uno de los pilares fundamentales para controlar su expansión. Por otro lado, entre los numerosos efectos de la pandemia actual, conviene destacar los relacionados con la interrupción de los servicios básicos de salud, entre ellos, los programas de vacunación que están sufriendo importantes caídas y demoras en la mayoría de los países. En esta conferencia se abordarán las diferentes vacunas que se están en progreso para COVID-19, las tecnologías utilizadas y los adelantos en su desarrollo, así como la importancia de reestablecer y mantener los sistemas de inmunización.

Objetivos:
• Conocer las nuevas vacunas que están en desarrollado en el mundo para COVID-19.
• Describir el avance del proceso de desarrollo de las diferentes vacunas para COVID-19.
• Reconocer la importancia de la vacunación en el contexto de la pandemia.

Moderator:
Lars-Åke Söderlund, President, Community Pharmacy Section FIP President, Community Pharmacy Section
Sweden

Panellists:
1. Jelmer Faber, Community pharmacist and Co-founder of PharmaSwap.com, Royal Dutch Pharmacists’ Association - the Netherlands
2. Rikke Løvig Simonsen, Chair PharmaDanmark - Denmark
3. Frédéric Bassi, President of the Industrial Pharmacists Section French Chamber of Pharmacists - France

Moderator: Ross McKinnon (College of Medicine and Public Health, Australia)

Speakers: Colin Pouton (Monash Institute of Pharmaceutical Sciences, Australia), Nikolai Petrovsky, Founder and CEO, Vaxine (Australia)

Moderator: Ema Paulino

Panelists: Paul Sinclair, Yong Pei Chean, Faraz Ashraf, Manjiri Gharat, Indre Treciokiene, Samira Shammas

Slides

Moderator: Nai-Hwa Mei
Panellists: Anasemon Aioub, Edurne Fdez. de Gamarra Martínez

Moderator: Rula Darwish

Speakers:Zeid Kilani, Falah Eddy, Ian Bates, Lina Bader, Dalia Bajis, Kirstie Galbraith

Panelists: Shepard Mhalaba, Asmaa Al Hagan, Desak Ernawati, Arit Udoh

Moderator: Catherine Duggan

Panellists: Ema Paulino, Ian Bates, Giovanni Pauletti

Moderator: Prof Ashok Soni

Panellists: Dr Michael Moore, Prof. Justin Ortiz

Moderator: Ema Paulino

Panellists: Bram Palache, Matthew Downham, Hanne Andresen, 

Moderator: Catherine Duggan

Panellists: Dominique Jordan, Sónia Queirós, Ann Lindstrand, Duarte Santos, Jane Barratt, Radu Costin Ganescu

Moderator: Lars-Åke Söderlund

Panellists: Glenis Kathleen Scadding, Gonçalo Sousa Pinto, Sundeep Santosh Salvi.

Speakres: Sabiha Essack and FIP Lead, Philip Howard, Catherine Duggan

The presentation is available here. Read the Covid-19 Special Collection by Pharmacy Education here. More on Pharmacy Education. 

The presentation is available here.

The presentation is available here.

OBJETIVOS
• Conocer las áreas de impacto del COVID-19 en el sistema de salud.
• Describir los efectos del COVID-19 en la salud mental de los farmacéuticos y otros trabajadores de salud.
• Desarrollar un enfoque ampliado de los resultados generados por la pandemia que sirvan para el diseño de estrategias futuras de resiliencia.

The Quantitative Sciences group is focused on quantitative data analysis to support program strategies for therapeutic projects that the foundation funds. This effort extends across all therapeutic areas in which the foundation is involved including maternal & child health, family planning, malaria, tuberculosis, neglected tropical diseases, HIV, and pandemic preparedness. He and his team are strong advocates of making research data “always FAIR and sometimes OPEN” to improve the impact data can have towards the problem it was collected to address, and beyond.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr. Roopa Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Taghreed is a professional expert in the pharmaceutical industry in the MENA region. In 2011, she founded Professional Effective Solutions, a company that offers consultation to pharmaceutical companies in formulating effective business plans; new products launch strategies to meet future market trends as well as turnaround management.

During the period from 1/2016 till 12/ 2016 she also held the position of Strategic Healthcare Advisor at the First Energy Bank in Abu Dhabi.

Taghreed had an instrumental role in the dramatic growth and success of Hikma in the MENA region. She was also an important member of the Hikma IPO team that helped take Hikma through the process of its transformation to an internationally recognized public company listed on the London Stock Exchange in Nov 2005.

Taghreed holds a BS.C degree in Pharmaceutical Sciences and two Master degrees from INSEAD Business School; “Executive MBA” in 2007 and “Consulting and Coaching for Change” in 2012.

Today, besides her consultancy services, Taghreed sits on the Board of other pharmaceutical companies in Jordan, Switzerland, Tunisia and the UAE, where she provides guidance and support.

The presentation is available here.